<SEC-DOCUMENT>0001753926-25-001486.txt : 20250915
<SEC-HEADER>0001753926-25-001486.hdr.sgml : 20250915
<ACCEPTANCE-DATETIME>20250915160218
ACCESSION NUMBER:		0001753926-25-001486
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		13
FILED AS OF DATE:		20250915
DATE AS OF CHANGE:		20250915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rocket Lab Corp
		CENTRAL INDEX KEY:			0001819994
		STANDARD INDUSTRIAL CLASSIFICATION:	GUIDED MISSILES & SPACE VEHICLES & PARTS [3760]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				392182599
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285707
		FILM NUMBER:		251314314

	BUSINESS ADDRESS:	
		STREET 1:		3881 MCGOWEN STREET
		CITY:			LONG BEACH
		STATE:			CA
		ZIP:			90808
		BUSINESS PHONE:		714-465-5737

	MAIL ADDRESS:	
		STREET 1:		3881 MCGOWEN STREET
		CITY:			LONG BEACH
		STATE:			CA
		ZIP:			90808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rocket Lab USA, Inc.
		DATE OF NAME CHANGE:	20210831

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Vector Acquisition Corp
		DATE OF NAME CHANGE:	20200803
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>g084949_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(5)<BR>
Registration Statement No. 333-285707 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Prospectus Supplement &nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(To Prospectus dated March 11, 2025) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Rocket
Lab Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><FONT STYLE="font-size: 10pt"><IMG SRC="img001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $750,000,000</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have entered into a sales
agreement (the &ldquo;sales agreement&rdquo;) with BofA Securities, Inc., Cantor Fitzgerald &amp; Co., BTIG, LLC, KeyBanc Capital
Markets Inc., Citizens JMP Securities, LLC, Needham &amp; Company, LLC and Roth Capital Partners, LLC, as our sales agents (the
&ldquo;sales agents&rdquo;), relating to the sale of shares of our common stock, par value $0.0001 per share (&ldquo;common stock&rdquo;),
offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we
may offer and sell shares of our common stock from time to time through or to the sales agents, acting as our agents or principal,
having an aggregate offering price of up to $750,000,000. As of the date of this prospectus supplement, we have sold shares of
our common stock with an aggregate gross sales price of approximately $396.6 million under the sales agreement, dated as of March
11, 2025, relating to the offering of shares of our common stock having an aggregate offering price of up to $500,000,000 (the
&ldquo;prior sales agreement&rdquo;). In connection with entering into the sales agreement, we are terminating the prior sales
agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sales of shares of our common stock under this prospectus supplement
and the accompanying prospectus, if any, may be made by any method deemed to be an &ldquo;at the market offering&rdquo; as defined
in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). The sales agents
are not required to sell any specific number or dollar amount of shares of our common stock. The sales agents have agreed to use
their commercially reasonable efforts to sell on our behalf all of the shares of common stock requested to be sold by us, consistent
with their normal trading and sales practices, on mutually agreed terms between the sales agents and us. There is no arrangement
for funds to be received in any escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The sales agents will be entitled to compensation under the
terms of the sales agreement at a commission rate equal to up to 3.0%
of the gross sales price per share sold. In connection with the sale of common stock on our behalf, the sales agents will be deemed
to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act, and the compensation of the sales agents will be deemed
to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to the sales agents with
respect to certain liabilities, including liabilities under the Securities Act. See &ldquo;Plan of Distribution&rdquo; for additional
information regarding compensation to be paid to the sales agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our common stock is traded on The Nasdaq Capital Market under
the symbol &ldquo;RKLB&rdquo;. On September 12, 2025, the last reported sale price of our common stock was $53.34 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investing in our common stock involves a high degree of risk.
You should review carefully the risks and uncertainties described under the heading &ldquo;Risk Factors&rdquo; beginning on page
S-5 of this prospectus supplement, the accompanying prospectus, and under similar headings in the other documents that are incorporated
by reference into this prospectus supplement. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Neither the Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement
or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B>&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>BofA
    Securities</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Cantor</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>BTIG</B></FONT></TD>
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Citizens
    Capital Markets</B></FONT></TD>
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>KeyBanc
    Capital Markets</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Needham
    &amp; Company</B></FONT></TD>
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Roth
    Capital Partners</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date
of this prospectus supplement is September 15, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>TABLE OF CONTENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Prospectus Supplement </B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a001_v1"><FONT STYLE="font-size: 10pt">ABOUT
    THIS PROSPECTUS SUPPLEMENT</FONT></A></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-iii&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a002_v1"><FONT STYLE="font-size: 10pt">CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-v</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a003_v1"><FONT STYLE="font-size: 10pt">SUMMARY</FONT></A></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a004_v1">THE
                                    OFFERING</A></FONT></P></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-3</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="#a005_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif">RISK FACTORS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-5</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#a006_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-7</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#a007_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND POLICY</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-8</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#a008_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DILUTION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-9</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#a009_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-11</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#a010_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-13</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#a011_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-13</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#a012_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-13</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#a013_v1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION BY REFERENCE</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-14</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Prospectus </B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 96%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    </TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b001_v1"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b002_v1"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">2</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b003_v1"><FONT STYLE="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">3</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b004_v1"><FONT STYLE="font-size: 10pt">THE COMPANY</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">5</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b005_v1"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">6</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b006_v1"><FONT STYLE="font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">7</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b007_v1"><FONT STYLE="font-size: 10pt">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">15</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b008_v1"><FONT STYLE="font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">21</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b009_v1"><FONT STYLE="font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">22</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b010_v1"><FONT STYLE="font-size: 10pt">SELLING STOCKHOLDERS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b011_v1"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">26</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b012_v1"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">29</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b013_v1"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">29</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#b014_v1"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">29</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Neither we nor the sales
agents (or any of their affiliates) have authorized anyone to provide you with information different from that contained or incorporated
by reference in this prospectus supplement, the accompanying prospectus or any free writing prospectus prepared by us or on our
behalf. Neither we nor the sales agents (or any of their affiliates) take any responsibility for, or can provide any assurance
as to the reliability of, any information other than the information contained or incorporated by reference in this prospectus
supplement, the accompanying prospectus or any free writing prospectus prepared by us or on our behalf. We and the sales agents
are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>You should assume that the information appearing or incorporated
by reference in this prospectus supplement, the accompanying prospectus or any free writing prospectus prepared by us or on our
behalf is accurate only as of their respective dates or on the date or dates which are specified in such documents, and that any
information in documents that we have incorporated by reference is accurate only as of the date of such document incorporated by
reference. Our business, financial condition, liquidity, results of operations and prospects may have changed since those dates.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a001_v1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 11, 2025, Rocket Lab USA, Inc., a Delaware corporation,
our predecessor, filed with the SEC an automatic registration statement on Form S-3ASR (File No. 333-285707) (the &ldquo;Automatic
Shelf Registration Statement&rdquo;) utilizing a shelf registration process relating to certain securities that may be offered
by us, including the securities described in this prospectus supplement, which became effective automatically upon filing. On May
27, 2025, we filed Amendment No. 1 to the Automatic Shelf Registration Statement pursuant to Rule 414 under the Securities Act,
to adopt the Automatic Shelf Registration Statement of Rocket Lab USA, Inc. following the Holding Company Reorganization (as defined
below), which amendment became effective automatically upon filing. Unless the context otherwise indicates, references in this
prospectus supplement to &ldquo;Rocket Lab&rdquo;, &ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;us&rdquo; refer, collectively,
to Rocket Lab Corporation, a Delaware corporation, and its consolidated subsidiaries, and prior to the Holding Company Reorganization
(defined below), to our predecessor Rocket Lab USA, Inc. and its consolidated subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This document is in two parts. The first part is this prospectus
supplement, which describes the specific terms of this offering of our common stock and certain other matters relating to us and
our business. The second part, the accompanying prospectus, contains and incorporates by reference important business and financial
information about us, a description of our common stock and certain other information about us and this offering. This prospectus
supplement and the accompanying prospectus are part of a registration statement that we filed with the SEC using a &ldquo;shelf&rdquo;
registration process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information contained in this prospectus supplement may
add, update or change information contained in the accompanying prospectus or in documents that we file or have filed with the
SEC. You should read both this prospectus supplement and the accompanying prospectus, together with additional information described
below under the headings &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation of Certain Documents by Reference.&rdquo;
To the extent the information contained in this prospectus supplement differs or varies from the information contained in the accompanying
prospectus or documents incorporated by reference filed before the date of this prospectus supplement, the information in this
prospectus supplement will supersede such information. Any statement modified or superseded by a statement made in a subsequently
filed document that is incorporated or deemed to be incorporated by reference in this prospectus supplement will not be deemed,
except as so modified or superseded, to constitute a part of this prospectus supplement. For further information, we refer you
to our Registration Statement, including its exhibits, of which this prospectus supplement and the accompanying prospectus form
a part. We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and therefore file reports and other information with the SEC. Statements contained in this prospectus supplement
and the accompanying prospectus about the provisions or contents of any agreement or other document are only summaries. If SEC
rules require that any agreement or document be filed as an exhibit to the Registration Statement, you should refer to that agreement
or document for its complete contents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Neither we nor the sales agents have authorized anyone to provide
you with any information other than that contained or incorporated by reference in this prospectus supplement and the accompanying
prospectus, along with the information contained in any free writing prospectuses we have authorized for use in connection with
this offering. Neither we nor the sales agents take any responsibility for, and can provide no assurance as to the reliability
of, any other information that others may give you. This prospectus supplement and the accompanying prospectus is an offer to sell
only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information appearing in this prospectus supplement and
the accompanying prospectus is accurate only as of the date on the front of the document and that any information we have incorporated
by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this
prospectus supplement and the accompanying prospectus, or any sale of securities. Our business, financial condition, results of
operations and prospects may have changed since those dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We use various trademarks and trade names in our business, including
without limitation our corporate name and logo. All other trademarks or trade names referred to in this prospectus are the property
of their respective owners. Solely for convenience, the trademarks and trade names in this prospectus may be referred to without
the &reg; and &trade; symbols, but such references should not be construed as any indicator that their respective owners will not
assert, to the fullest extent under applicable law, their rights thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a002_v1"></A>FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">This prospectus supplement, the accompanying
prospectus and the documents incorporated by reference herein and therein contains forward-looking statements within the meaning
of Section 27A of the Securities Act and Section 21E of the Exchange Act. Our forward-looking statements include, but are not limited
to, statements regarding our or our management team&rsquo;s expectations, hopes, beliefs, intentions or strategies regarding the
future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances,
including any underlying assumptions, are forward-looking statements. The words &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;could,&rdquo; &ldquo;expect,&rdquo; &ldquo;intends,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo;
&ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;would&rdquo; and similar expressions
may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions
that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking
statements. Forward-looking statements in this report may include, for example, statements about:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>Our ability to effectively manage future growth and achieve operational efficiencies;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>any inability of us to operate our Electron Launch Vehicle (&ldquo;Electron&rdquo;) at its anticipated launch rate, including
due to any government action related to launch failure and our ability to operate, could adversely impact our business, financial
condition and results of operations;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>our inability to develop our Neutron Launch Vehicle (&ldquo;Neutron&rdquo;) or significant delays in developing Neutron could
adversely impact our business, financial condition and results of operations;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>our inability to utilize our launch pads at our private launch complex in Mahia, New Zealand or at NASA&rsquo;s Wallops Flight
Facility, at Wallops Island, Virginia with sufficient frequency to support our launch cadence and future related revenue growth
expectations;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>our spacecraft, space systems or space system components failing to operate as intended could have a material adverse effect
on our business, financial condition and results of operations;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>changes in the competitive and highly regulated industries in which we operate, variations in operating performance across
competitors, changes in laws and regulations affecting our business and changes in our capital structure;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>changes in governmental policies, priorities, regulations, mandates or funding for programs in which we or our customers participate,
which could negatively impact our business;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>changes in trade policies, including tariffs;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>loss of, or default by, one or more of our key customers or inability of customers to fund contractual commitments, which could
result in a decline in future revenues, cancellation of contracted launches or space systems orders or termination or default of
existing agreements;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the inability to comply with, and costs associated with complying, any applicable regulations, and specifically, U.S. government
contract regulations, which could result in loss of contract opportunities, contract modifications or termination, assessment of
penalties and fines, and suspension or debarment from U.S. government contracting or subcontracting;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>success in retaining or recruiting, or changes required in, officers, key employees or directors, and our ability to attract
and retain key personnel, including Sir Peter Beck, our President, Chief Executive Officer and Chairman;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>defects in or failure of our products to operate in the expected manner, including any launch failure, which could result in
a loss of revenue, impact our business, prospects and profitability, increase our insurance rates and damage our reputation and
ability to obtain future customers;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>inability or failure to protect intellectual property;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>disruptions in the supply of key raw materials or components used to produce our products or increases in prices of raw materials;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the ability to implement our business plans, forecasts and other expectations, including the integration of recently acquired
businesses, and to identify and realize additional opportunities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the diversion of management&rsquo;s attention and consumption of resources as a result of acquisitions of other companies and
success in integrating and otherwise achieving the benefits of recent and potential acquisitions;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>our inability to effectively integrate or benefit from recently purchased assets or businesses;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>global inflation and interest rates;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>impacts of the wars in Ukraine, Israel, Iran or other global conflicts;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>fluctuations in foreign exchange rates;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the risk of downturns in government and commercial launch services and spacecraft industries;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>our ability to anticipate changes in the markets for rocket launch services, mission services, spacecraft and spacecraft components;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the inability or failure to comply with contractual requirements or covenants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>failure to maintain adequate operational and financial resources or raise additional capital or generate sufficient cash flows;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>any significant disruption in or unauthorized access to our computer systems or those of third parties that we utilize in our
operations, including those relating to cybersecurity or arising from cyber-attacks; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>other factors detailed under the section of this prospectus supplement, the accompanying prospectus and the documents incorporated
by reference herein and therein titled &ldquo;Risk Factors.&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Should one or more of these risks or uncertainties materialize,
or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking
statements. Some of these risks and uncertainties may in the future be amplified by a global crises and/or any response to such
a crisis and there may be additional risks that we consider immaterial or which are unknown. It is not possible to predict or identify
all such risks. It is not possible to predict or identify all such risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The forward-looking statements contained in this prospectus
supplement, the accompanying prospectus and the documents incorporated by reference herein and therein are based on information
available to us at the time of such filing and current expectations, forecasts, assumptions and beliefs concerning future developments
and their potential effects, and involve a number of judgments, risks and uncertainties. There can be no assurance that future
developments affecting us will be those that we have anticipated. Accordingly, forward-looking statements should not be relied
upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements
to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise,
except as may be required under applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<div STYLE="BORDER:solid BLACK 2PX;padding-left:2%;padding-Right:2%;width:96%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a003_v1"></A>SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>This summary highlights selected information contained or
incorporated by reference in this prospectus supplement, the accompanying prospectus or any free writing prospectus prepared by
us or on our behalf. It does not contain all of the information that you should consider before investing in shares of our common
stock. You should carefully read this entire prospectus supplement, the accompanying prospectus and documents incorporated herein
and therein, including the factors described or referred to under the heading &ldquo;Risk Factors&rdquo; in our Annual Report on
Form 10-K and our Quarterly Reports on Form 10-Q. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Rocket Lab is an end-to-end space company
with an established track record of mission success. We deliver reliable launch services, spacecraft design services, spacecraft
components, spacecraft manufacturing and other spacecraft and on-orbit management solutions that make it faster, easier and more
affordable to access space.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">While our business has historically
been centered on the development of small-class launch vehicles and the related sale of launch services, we are currently innovating
in the areas of medium-class launch vehicles and launch services, space systems design and manufacturing, on-orbit management solutions,
and space data applications. Each of these initiatives addresses a critical component of the end-to-end solution and our value
proposition for the space economy:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>Launch Services is the design, manufacture, and launch of orbital rockets to deploy payloads to various Earth orbits and interplanetary
destinations.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>Space Systems is the design and manufacture of spacecraft components and spacecraft program management services, space data
applications and mission operations.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Electron is our orbital small launch
vehicle that was designed from the ground up to accommodate a high launch rate business model to meet the growing and dynamic needs
of our customers for small launch services. Since its maiden launch in 2017, Electron has become the leading small spacecraft launch
vehicle delivering over 200 spacecraft to orbit for government and commercial customers across 64 successful missions through June
30, 2025. In 2024, Electron was the second most frequently orbital launched rocket by companies operating in the United States
and the second most frequent orbital launcher globally. Our launch services program has seen us develop many industry-leading innovations,
including 3D printed electric turbo-pump rocket engines, fully carbon composite first stage fuel tanks, a private orbital launch
complex, a rocket stage that can be configured to convert into a highly capable spacecraft on orbit, and the potential ability
to successfully recover a stage from space, providing a path to reusability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">In March 2021, we announced plans to
develop our reusable-ready medium-capacity Neutron launch vehicle that will increase the payload capacity of our space launch vehicles
to approximately 15,000 kg for expendable launches to low Earth orbit and lighter payloads for reusable configurations and into
higher orbits. Neutron will be tailored for commercial and U.S. government constellation launches and ultimately configurable for
and capable of human space flight, enabling us to provide crew and cargo resupply to space stations. Neutron will also provide
a dedicated service to orbit for larger civil, defense and commercial payloads that need a high level of schedule control and high-flight
cadence. We expect to be able to leverage Electron&rsquo;s flight heritage across various vehicle subsystems designs, launch complexes
and ground station infrastructure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Our space systems initiatives are supported
by the design and manufacture of our spacecraft family along with a range of components, software and services for spacecraft,
including reaction wheels, star trackers, radios, separation systems, solar solutions, command and control spacecraft software,
high voltage space grade battery solutions, and additional products in development to serve a wide variety of sub-system functions.
We entered this market with our acquisition of leading spacecraft components manufacturer Sinclair Interplanetary, and have since
expanded our market participation with the acquisitions of Planetary Systems Corporation, SolAero Technologies Corp. and aerospace
software firm Advanced Solutions, Incorporated. Each of these strategic acquisitions brought incremental vertically-integrated
capabilities for our own spacecraft family and also enabled Rocket Lab to deliver high-volume manufacturing of critical spacecraft
components and software solutions at scale prices to the broader spacecraft merchant market. Our spacecraft family, which are configurable
for a range of low Earth orbit, medium Earth orbit, geosynchronous orbit and interplanetary missions enable us to offer an end-to-end
mission solution encompassing launch, full spacecraft manufacturing, ground services and mission operations to provide customers
with streamlined access to orbit with Rocket Lab as a single mission partner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

</div>

<!-- Field: Page; Sequence: 9; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<div STYLE="BORDER:solid BLACK 2PX;padding-left:2%;padding-Right:2%;width:96%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Our predecessor entity,
Rocket Lab USA, Inc., completed a merger with Vector Acquisition Corporation (&ldquo;Vector&rdquo;) on August 25, 2021 (the &ldquo;Business
Combination&rdquo;), in conjunction with which Vector changed its name to Rocket Lab USA, Inc. (&ldquo;Rocket Lab USA&rdquo;).
On May 23, 2025, Rocket Lab USA implemented a holding company reorganization in accordance with Section 251(g) of the General Corporation
Law of the State of Delaware (the &ldquo;Holding Company Reorganization&rdquo;) pursuant to the Agreement and Plan of Merger, dated
as of May 23, 2025 (the &ldquo;Merger Agreement&rdquo;), by and among Rocket Lab USA, Rocket Lab Corporation and Rocket Lab Merger
Sub, Inc., a newly-formed Delaware corporation (&ldquo;Merger Sub&rdquo;). Pursuant to the Holding Company Reorganization, Rocket
Lab USA merged with and into Merger Sub, a direct wholly owned subsidiary of Rocket Lab Corporation and an indirect wholly owned
subsidiary of Rocket Lab USA, with Rocket Lab USA surviving as a direct wholly owned subsidiary of Rocket Lab Corporation. At the
Effective Time (as defined in the Merger Agreement), (i) the separate existence of Merger Sub ceased, (ii) each share of Rocket
Lab USA common stock, par value $0.0001 per share (&ldquo;Rocket Lab USA Common Stock&rdquo;), issued and outstanding immediately
prior to the Effective Time, was automatically converted into one share of Rocket Lab Corporation common stock, par value $0.0001
per share, having the same designation, rights, powers, and preferences, and qualifications, limitations, and restrictions as a
share of Rocket Lab USA Common Stock immediately prior to consummation of the Holding Company Reorganization and (iii) each share
of Rocket Lab USA Series A Convertible Participating Preferred Stock, par value $0.0001 per share (&ldquo;Rocket Lab USA Preferred
Stock&rdquo;), issued and outstanding immediately prior to the Effective Time was automatically converted into one share of Rocket
Lab Corporation Series A Convertible Participating Preferred Stock, par value $0.0001 per share, having the same designation, rights,
powers, and preferences, and qualifications, limitations, and restrictions as a share of Rocket Lab USA Preferred Stock immediately
prior to consummation of the Holding Company Reorganization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Our corporate headquarters
are located at 3881 McGowen Street, Long Beach, California 90808, and our telephone number is (714) 465-5737. Our website is located
at www.rocketlabcorp.com. Information contained on or accessible through our website is not a part of or incorporated by reference
into this prospectus supplement, and the inclusion of our website address in this prospectus supplement is an inactive textual
reference only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</div>
<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<div STYLE="BORDER:solid BLACK 2PX;padding-left:2%;padding-Right:2%;width:96%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 24.5pt"><B><A NAME="a004_v1"></A>THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>The following summary of the offering contains basic information
about the offering and our common stock and is not intended to be complete. It does not contain all the information that may be
important to you. For a more complete understanding of our common stock, please refer to the section of the accompanying prospectus
titled &ldquo;Description of Securities.&rdquo; </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="width: 76%; padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 8pt"><FONT STYLE="font-size: 10pt">Rocket Lab Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Common stock offered by us</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 8pt"><FONT STYLE="font-size: 10pt">Shares of our common stock having an aggregate offering price of up to $750,000,000.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 8pt"><FONT STYLE="font-size: 10pt">Common stock outstanding after the offering</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Up to 498,021,407 shares of common stock, assuming sales of 14,060,742 shares of common stock, based on the public offering price of $53.34 per share of common stock, which was the last reported sale price of our common stock on The Nasdaq Capital Market on September 12, 2025. The actual number of shares issued will vary depending on how many shares of our common stock we choose to sell and the prices at which such sales occur.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 8pt"><FONT STYLE="font-size: 10pt">Manner of Offering</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&ldquo;At the market offering&rdquo; that may be made from time to time through our sales agents. See &ldquo;Plan of Distribution&rdquo;.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 8pt"><FONT STYLE="font-size: 10pt">Use of Proceeds</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">We currently intend to use the net proceeds from this offering, after deducting commissions and offering expenses payable by us, to fund future growth, including potential future acquisitions, and for general corporate and working capital purposes. We previously entered into a nonbinding term sheet with respect to the potential acquisition of Mynaric AG (&ldquo;Mynaric&rdquo;), and may use a portion of the net proceeds from this offering to pay the cash portion of the purchase price, if any, for the Mynaric acquisition, if completed, and to pay fees and expenses related thereto. See &ldquo;Use of Proceeds&rdquo;.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 8pt"><FONT STYLE="font-size: 10pt">Risk Factors</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Investing in our common stock involves a high degree of risk. Please read the information contained in and incorporated by reference under the heading &ldquo;Risk Factors&rdquo; in this prospectus supplement and under similar headings in the other documents that are filed after the date hereof and incorporated by reference into this prospectus supplement and the accompanying prospectus.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Nasdaq Capital Market Symbol</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Our common stock is listed on The Nasdaq Capital Market under the symbol &ldquo;RKLB.&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The number of shares of our common stock that will be outstanding
immediately after this offering as shown above is based on 483,960,665 shares outstanding as of September 1, 2025, and excludes
as of that date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>6,723,357 shares of common stock issuable upon the exercise of outstanding stock options at a weighted-average exercise price
of $1.08 per share;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>15,480,262 shares of common stock reserved for issuance upon settlement of restricted stock units;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>91,901,247 shares of our common stock reserved for future issuance under the Rocket Lab 2021 Stock Option and Incentive Plan
(the &ldquo;2021 Plan&rdquo;). The number of shares reserved for issuance under the 2021 Plan automatically increases each January
1 by 5% of the outstanding number of shares of common stock on the immediately preceding December 31, or such lesser amount as
determined by the plan administrator;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

</div>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<div STYLE="BORDER:solid BLACK 2PX;padding-left:2%;padding-Right:2%;width:96%">
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>19,861,563 shares of common stock reserved for future issuance under our 2021 Employee Stock Purchase Plan (the &ldquo;2021
ESPP&rdquo;). The number of shares reserved for issuance under the 2021 ESPP automatically increases on January 1 of each year
to January 1, 2031 by the least of (i) 9,980,000 shares of common stock, (ii) 1% of the number of shares of common stock outstanding
as of the close of business on the immediately preceding December 31 or (iii) the number of shares of common stock as determined
by our board of directors (the &ldquo;Board&rdquo;);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>45,951,250 shares of common stock reserved for issuance upon conversion of the Company&rsquo;s Series A Convertible Participating
Preferred Stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>all shares of common stock issuable upon conversion of our outstanding 4.250% convertible senior notes due 2029; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>all shares of common stock that may be issuable in connection with potential future acquisitions, if any.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

</div>
<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a005_v1"></A>RISK FACTORS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Before you invest in shares of our common stock, in addition
to the other information in this prospectus supplement and the accompanying prospectus, you should carefully read and consider
the risk factors described under the heading &ldquo;Risk Factors&rdquo; contained in our most recent Annual Report on Form 10-K
and any subsequent Quarterly Reports on Form 10-Q, which are incorporated by reference into this prospectus supplement and the
accompanying prospectus, as the same may be updated from time to time by our future filings under the Exchange Act. Each of the
risks described in these documents could materially and adversely affect our business, financial condition, liquidity, results
of operations and prospects, and could result in a partial or complete loss of your investment. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>In connection with the forward-looking statements that appear
in this prospectus supplement and the accompanying prospectus, you should also carefully review the cautionary statement referred
to under &ldquo;Forward-Looking Statements&rdquo; in this prospectus supplement. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to This Offering </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We will have broad discretion in the use of the net proceeds
from this offering and may not use them effectively.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently intend to use the net proceeds of this offering
for to fund future growth, including potential future acquisitions, and for general corporate and working capital purposes, as
further described in the section of this prospectus supplement titled &ldquo;Use of Proceeds.&rdquo; We will have broad discretion
in the application of the net proceeds and investors will be relying on the judgment of our management regarding the application
of the proceeds of this offering, including with respect to potential future acquisitions. The failure by our management to apply
these funds effectively could harm our business, financial condition and results of operations. Additionally, any future acquisitions
for which we may use these funds, such as the potential Mynaric acquisition, may not prove to be successful or effective in achieving
management&rsquo;s objectives. Pending their use, we may invest the net proceeds from this offering in short-term, interest-bearing
instruments. These investments may not yield a favorable return, or any return, to us or our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>This offering and future issuances of our common stock
could be dilutive to our earnings per share. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The issuance and sale by us of any shares of our common stock
in this offering, the receipt of the net proceeds therefrom and the use of those net proceeds could have a dilutive effect on our
earnings per share. Additional issuances of our common stock could also be dilutive to our earnings per share. The issuance or
sale by us of our common stock, including the sale by us of shares in this offering, could also adversely affect the trading price
of our common stock and our ability to raise capital through future offerings of equity or equity-related securities. In addition,
if we are unable to apply any net proceeds we may receive from this offering or from other issuances or sales of our common stock
to make investments that generate sufficient revenues to offset the dilutive impact of the issuance by us of shares of our common
stock in this offering or from any other such issuances of our common stock, there will be further dilution of our earnings per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We do not intend to pay dividends on our common stock,
so any returns will be limited to the value of our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently anticipate that we will retain any future earnings
to finance the continued development, operation and expansion of our business. As a result, we do not anticipate declaring or paying
any cash dividends or other distributions in the foreseeable future. Further, if we were to enter into a credit facility or issue
debt securities or preferred stock in the future, we may become contractually restricted from paying dividends. If we do not pay
dividends, our common stock may be less valuable because stockholders must rely on sales of their common stock after price appreciation,
which may never occur, to realize any gains on their investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The actual number of shares of common stock we will issue
under the sales agreement, at any one time or in total, is uncertain. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to certain limitations in the sales agreement and compliance
with applicable law, we have the discretion to deliver a placement notice to the sales agents at any time throughout the term of
the sales agreement. The per share price of the shares of common stock that are sold by the sales agents after delivering a placement
notice will fluctuate based on the market price of our common stock during the sales period and limits we set with the sales agents.
Because the price per share of each share of common stock sold will fluctuate based on the market price of our common stock during
the sales period, it is not possible at this stage to predict the number of shares of common stock that will be ultimately issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The common stock offered hereby will be sold in &ldquo;at
the market offerings,&rdquo; and investors who buy shares at different times will likely pay different prices. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investors who purchase shares in this offering at different
times will likely pay different prices, and so may experience different levels of dilution and different outcomes in their investment
results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold, and there is
no minimum or maximum sales price. Investors may experience a decline in the value of their shares as a result of share sales made
at prices lower than the prices they paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The sale of our common stock in this offering and any
future sales of our common stock may depress our stock price and our ability to raise funds in new stock offerings.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sales of our common stock in this offering and the public market
following this offering could lower the market price of our common stock. Sales may also make it more difficult for us to sell
equity securities or equity-related securities in the future at a time and price that our management deems acceptable, or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a006_v1"></A>USE OF PROCEEDS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may issue and sell shares of our common stock having aggregate
gross sales proceeds of up to $750 million from time to time pursuant to the sales agreement. The amount of proceeds from this
offering will depend upon the number of shares of our common stock sold and the market price at which they are sold. Because there
is no minimum offering amount required as a condition to close this offering, the actual total public offering amount, commissions
and proceeds to us, if any, are not determinable at this time. There can be no assurance that we will sell any shares under or
fully utilize the sales agreement as a source of financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently intend to use the net proceeds from this offering,
after deducting commissions and offering expenses payable by us, for to fund future growth, including potential future acquisitions,
and for general corporate and working capital purposes. We have entered into a nonbinding term sheet with respect to the potential
acquisition of Mynaric, and may use a portion of the net proceeds from this offering to pay the cash portion of the purchase price,
if any, for the Mynaric acquisition, if completed, and to pay fees and expenses related thereto. Pending these uses, we may invest
the net proceeds from this offering in short-term, interest-bearing instruments. Accordingly, we will retain broad discretion over
the use of these proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a007_v1"></A>DIVIDEND POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have never declared or paid any cash dividends on our capital
stock, and we do not currently intend to pay any cash dividends for the foreseeable future. It is the present intention of our
Board to retain all earnings, if any, for use in our business operations and, accordingly, our Board does not anticipate declaring
any dividends in the foreseeable future. The payment of cash dividends in the future will be dependent upon our revenues and earnings,
if any, capital requirements and general financial condition. The payment of any cash dividends is within the discretion of our
Board. Further, our ability to declare dividends may be limited by the terms of financing or other agreements entered into by it
or its subsidiaries from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a008_v1"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you invest in our common stock, your interest will be diluted
immediately to the extent of the difference between the public offering price per share of our common stock and the as adjusted
net tangible book value per share of common stock after this offering. We calculate net tangible book value per share by dividing
our net tangible assets (tangible assets less total liabilities) by the number of shares of our common stock issued and outstanding
as of June 30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The net tangible book value of our common stock as of June 30,
2025 was approximately $688.5 million, or, approximately $1.44 per tangible book value per share represents the amount of our total
tangible assets less total liabilities divided by the total number of shares of our common stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dilution per share to new investors represents the difference
between the amount per share paid by purchasers for our common stock in this offering and the net tangible book value per share
of our common stock immediately following the completion of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">After giving effect to the sale of shares of common stock offered
by this prospectus at an assumed public offering price of $53.34 per share (the last reported sale price of our common stock on
The Nasdaq Capital Market on September 12, 2025), and after deducting commissions and estimated aggregate offering expenses payable
by us, our as adjusted net tangible book value as of June 30, 2025 would have been approximately $1,421.6 million, or approximately
$2.88 per share. This represents an immediate increase in net tangible book value of approximately $1.44 per share to our existing
stockholders and an immediate dilution in as adjusted net tangible book value of approximately $49.26 per share to purchasers of
our common stock in this offering, as illustrated by the following table:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 82%"><FONT STYLE="font-size: 10pt">Assumed public offering price per share</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; width: 5%"><FONT STYLE="font-size: 10pt">53.34</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Net tangible book value per share as of June 30, 2025</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">1.44</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">Increase in net tangible book value per share attributable to investors</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">1.44</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">As adjusted net tangible book value per share as of June 30, 2025 after giving effect to this offering</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">2.88</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">Dilution per share to investors purchasing our common stock in this offering</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 10pt">49.26</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table above assumes for illustrative purposes that an aggregate
of 14,060,742 shares of our common stock are sold at a price of $53.34 per share, the last reported sale price of our common stock
on The Nasdaq Capital Market on September 12, 2025, for aggregate gross proceeds of approximately $750 million. The shares sold
in this offering, if any, will be sold from time to time at various prices. An increase of $1.00 per share of common stock in the
price at which the shares of common stock are sold from the assumed offering price of $53.34 per share of common stock shown in
the table above, assuming all of our shares of common stock in the aggregate amount of $750 million during the term of the sales
agreement with the sales agents are sold at that price, would increase our adjusted net tangible book value per share of common
stock after the offering to $2.88 per share of common stock and would increase the dilution in net tangible book value per share
of common stock to new investors in this offering to $50.24 per share of common stock, after deducting commissions and estimated
offering expenses payable by us. A decrease of $1.00 per share of common stock in the price at which the shares of common stock
are sold from the assumed offering price of $53.34 per share of common stock shown in the table above, assuming all of our shares
of common stock in the aggregate amount of $750 million during the term of the sales agreement with the sales agents are sold at
that price, would decrease our adjusted net tangible book value per share of common stock after the offering to $2.88 per share
of common stock and would decrease the dilution in net tangible book value per share of common stock to new investors in this offering
to $48.28 per share of common stock, after deducting commissions and estimated aggregate offering expenses payable by us.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may choose to raise additional capital due to market conditions
or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent
that we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could
result in further dilution to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information discussed above is illustrative only and will
adjust based on the actual public offering price and other terms of this offering determined at pricing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The number of shares of our common stock that will be outstanding
immediately after this offering is based on 483,960,665 shares outstanding as of September 1, 2025. The number of shares outstanding
as of September 1, 2025, unless otherwise indicated, excludes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>6,723,357 shares of common stock issuable upon the exercise of outstanding stock options at a weighted-average exercise price
of $1.08 per share;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>15,480,262 shares of common stock reserved for issuance upon settlement of restricted stock units;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>91,901,247 shares of our common stock reserved for future issuance under the 2021 Plan. The number of shares reserved for issuance
under the 2021 Plan automatically increases each January 1 by 5% of the outstanding number of shares of common stock on the immediately
preceding December 31, or such lesser amount as determined by the plan administrator;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>19,861,563 shares of common stock reserved for future issuance under the 2021 ESPP. The number of shares reserved for issuance
under the 2021 ESPP automatically increases on January 1 of each year to January 1, 2031 by the least of (i) 9,980,000 shares of
common stock, (ii) 1% of the number of shares of common stock outstanding as of the close of business on the immediately preceding
December 31 or (iii) the number of shares of common stock as determined by our Board;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>45,951,250 shares of common stock reserved for issuance upon conversion of the Company&rsquo;s Series A Convertible Participating
Preferred Stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>all shares of common stock issuable upon conversion of our outstanding 4.250% convertible senior notes due 2029; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>all shares of common stock that may be issuable in connection with potential future acquisitions, if any.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as otherwise indicated, all information in this prospectus
supplement assumes no exercise of outstanding options or conversion of outstanding preferred stock or convertible notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a009_v1"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have entered into a sales agreement with BofA Securities,
Inc., Cantor Fitzgerald &amp; Co., BTIG, LLC, KeyBanc Capital Markets Inc., Citizens JMP Securities, LLC, Needham &amp; Company,
LLC and Roth Capital Partners, LLC, as sales agents, relating to the offer and sale from time to time of shares of our common stock
having an aggregate offering price of up to $750 million through the sales agents, acting as our agents, or directly to the sales
agents, acting as principal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sales of shares of our common stock, if any, under this prospectus
supplement and the accompanying prospectus will be made by any method permitted by law and deemed to be an &ldquo;at the market&rdquo;
offering as defined in Rule 415 promulgated under the Securities Act, including by ordinary brokers&rsquo; transactions through
the facilities of The Nasdaq Capital Market or otherwise at market prices prevailing at the time of sale, at prices related to
prevailing market prices or at negotiated prices, in block transactions or as otherwise permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The sales agents are not required to sell any specific number
or dollar amount of shares of common stock, but will use its commercially reasonable efforts, as our agents and consistent with
its normal trading and sales practices, to sell, subject to the terms of the sales agreement, shares of common stock, as agreed
upon by us and the sales agents from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In no event will the aggregate sales price of shares of our
common stock sold by us to or through the sales agents, acting as our agents or as principal pursuant to the sales agreement, exceed
$750 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the sale of shares of our common stock on
our behalf, the sales agents will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act, and the
compensation paid to the sales agents will be deemed to be underwriting commissions or discounts. We have agreed that we will indemnify
the sales agents against certain liabilities, including liabilities under the Securities Act, or contribute to payments that the
sales agents may be required to make in respect of those liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The remaining sales proceeds from the sale of any shares of
our common stock, after deducting any transaction fees, transfer taxes or similar fees, taxes or charges imposed by any governmental
or self-regulatory organization in connection with such sales, shall constitute the net proceeds from the sale of our common stock
offered by this prospectus supplement and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon its acceptance of instructions from us, the sales agents
have agreed to use their commercially reasonable efforts to sell shares of our common stock on the terms and subject to the conditions
set forth in the sales agreement. We will instruct the sales agents as to the amount of common stock to be sold by them as our
agents. We may instruct the sales agents not to sell our common stock if sales cannot be effected at or above a price designated
by us. We or the sales agents may at any time immediately suspend the offering of shares of our common stock through the sales
agents upon notice to the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The sales agents will provide written confirmation following
the close of trading on The Nasdaq Capital Market on each trading day on which shares of our common stock are sold through the
sales agents under the sales agreement. Each confirmation will include the number of shares of our common stock sold on that day,
the aggregate gross proceeds of such sales, the net proceeds of such sales and the compensation payable by us to the sales agents
in connection with such sales of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will pay the sales agents an aggregate fee equal to up to
3.0% of the gross proceeds from the sales of all shares of common stock sold through the sales agents under the sales agreement.
We have also agreed to reimburse the sales agents for their reasonable and documented out-of-pocket expenses, including the reasonable
fees, disbursements and expenses of counsel for the sales agents payable upon execution of the sales agreement in an amount not
to exceed $100,000, as well as ongoing disbursements
of counsel for the sales agents payable in the amount of up to $25,000
in connection with the transactions contemplated under the sales agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the terms of the sales agreement, we may also sell shares
of our common stock in negotiated transactions or as otherwise agreed with the sales agents, including sales to the sales agents,
as principal for their own account, at a price to be agreed upon at the time of sale. If we sell shares of our common stock in
a manner which is not an &ldquo;at the market&rdquo; offering, including sales to the sales agents, as principal for its own account,
we will enter into a separate terms agreement with the sales agents, and we will describe the terms of the offering of such shares
in a separate prospectus supplement or free writing prospectus if required. The sales agents do not have any obligation to purchase
shares of common stock from us as principal and may elect whether or not to do so in their sole and absolute discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Certain Relationships </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The sales agents and their affiliates are full service financial
institutions engaged in various activities, which may include sales and trading, commercial and investment banking, advisory, investment
management, investment research, principal investment, hedging, market making, brokerage and other financial and non-financial
activities and services. The sales agents and certain of their affiliates have, from time to time, provided, and may in the future
provide, a variety of these services to us and to persons and entities with relationships with us, for which they received or will
receive customary fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the ordinary course of their various business activities,
the sales agents and their affiliates, officers, directors and employees may purchase, sell or hold a broad array of investments
and actively trade securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments
for their own account and for the accounts of their customers, and such investment and trading activities may involve or relate
to our assets, securities and/or instruments (directly, as collateral securing other obligations or otherwise) and/or persons and
entities with relationships with us. The sales agents and their affiliates may also communicate independent investment recommendations,
market color or trading ideas and/or publish or express independent research views in respect of such assets, securities or instruments
and may at any time hold, or recommend to clients that they should acquire, long and/or short positions in such assets, securities
and instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Selling Restrictions </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other than in the United States, no action has been taken by
us or the sales agents that would permit a public offering of the shares of common stock offered by this prospectus supplement
and the accompanying prospectus in any jurisdiction where action for that purpose is required. The shares offered by this prospectus
supplement may not be offered or sold, directly or indirectly, nor may this prospectus supplement or any other offering material
or advertisements in connection with the offer and sale of any such shares be distributed or published in any jurisdiction, except
under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into
whose possession this prospectus supplement comes are advised to inform themselves about and to observe any restrictions relating
to the offering and the distribution of this prospectus supplement. This prospectus supplement does not constitute an offer to
sell or a solicitation of an offer to buy any shares of common stock offered by this prospectus supplement in any jurisdiction
in which such an offer or a solicitation is unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should be aware that the laws and practices of certain countries
require investors to pay stamp taxes and other charges in connection with purchases of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a010_v1"></A>LEGAL MATTERS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The validity of the shares of our common stock offered hereby
will be passed upon for us by Goodwin Procter LLP, Redwood City, California. Certain legal matters in connection with this offering
will be passed upon for the sales agents by Latham &amp; Watkins, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a011_v1"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The financial statements of Rocket Lab USA, Inc. incorporated
by reference in this prospectus and the effectiveness of the Rocket Lab USA, Inc.&rsquo;s internal control over financial reporting
have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their report. Such
financial statements are incorporated by reference in reliance upon the report of such firm given upon their authority as experts
in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a012_v1"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are required to file annual, quarterly and current reports,
proxy statements and other information with the SEC. Our filings with the SEC are available to the public through the SEC&rsquo;s
website at <I>https://www.sec.gov</I>. In addition, we make available free of charge on our website (<I>https://www.rocketlabcorp.com</I>)
our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to those reports
as soon as reasonably practicable after such material is electronically filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have filed a registration statement on Form S-3 with the
SEC relating to the shares of our common stock covered by this prospectus supplement and the accompanying prospectus. This prospectus
supplement and the accompanying prospectus do not contain all of the information set forth in the registration statement. Whenever
a reference is made in this prospectus supplement or the accompanying prospectus to a contract or other document of ours, please
be aware that the reference is only a summary and that you should refer to the exhibits that are part of the registration statement
for a copy of the contract or other document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a013_v1"></A>INCORPORATION BY REFERENCE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SEC allows us to incorporate by reference the information
we file with the SEC, which means that we can disclose important information to you by referring you to those publicly available
documents. The information that we incorporate by reference in this prospectus supplement is considered to be part of this prospectus
supplement. Because we are incorporating by reference future filings with the SEC, this prospectus supplement is continually updated
and those future filings may modify or supersede some of the information included or incorporated in this prospectus supplement.
This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements
in this prospectus supplement or in any document previously incorporated by reference have been modified or superseded. This prospectus
supplement incorporates by reference the documents listed below and any documents subsequently filed by us with the SEC under Sections
13(a), 13(c), 14 or 15(d) of the Exchange Act (in each case, other than those documents or the portions of those documents deemed
furnished and not filed in accordance with SEC rules, including Items 2.02 and 7.01 of Form 8-K) until the offering of the securities
under the registration statement of which this prospectus supplement forms a part is terminated or completed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Report on&nbsp;Form&nbsp;10-K&nbsp;for
    the year ended December&nbsp;31, 2024, filed with the SEC on&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025008724/rklb-20241231.htm">February&nbsp;27,
    2025</A>, as amended by Amendment No. 1 on Form 10-K/A, filed with the SEC on&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025021054/rklb-20241231.htm">April
    30, 2025</A>;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quarterly Reports on
    Form 10-Q for the quarterly periods ended March 31, 2025 and June 30, 2025, filed with the SEC on&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025023857/rklb-20250331.htm">May
    8, 2025</A>&nbsp;and&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025038936/0001628280-25-038936-index.htm">August
    7, 2025</A>, respectively;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Reports on Form&nbsp;8-K&nbsp;filed
    with the SEC on&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025001137/rklb-20250107.htm">January&nbsp;10,
    2025</A>,&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000119312525052062/d897799d8k.htm">March 11, 2025</A>,&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025023816/rklb-20250508.htm">May
    8, 2025</A>,&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025027920/rklb-20250522.htm">May 27, 2025</A>,&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025030197/rklb-20250609.htm">June
    9, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/0001819994/000175392625001284/g084916_8k.htm">August
    12, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/0001819994/000162828025041402/rklb-20250825.htm">August
    29, 2025</A>; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The description of our
    capital stock contained in our Form 8-K12B filed with the SEC on&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1819994/000162828025027473/rklb-20250523.htm">May
    23, 2025</A>, including any amendments or reports filed for the purpose of updating such description.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon request, we will provide, without charge, to each person,
including any beneficial owner, to whom a copy of this prospectus supplement is delivered, upon written or oral request, a copy
of the documents incorporated by reference into this prospectus supplement but not delivered with the prospectus supplement. You
may request a copy of these filings, and any exhibits we have specifically incorporated by reference as an exhibit in this prospectus
supplement, at no cost by writing or telephoning us at the following address and telephone number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Rocket Lab Corporation&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">3881 McGowen Street&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Long Beach, California 90808&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attention: Corporate Secretary&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(714) 465-5737</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You may also access these documents, free of charge on the SEC&rsquo;s
website at <I>www.sec.gov</I> or on our website at <I>www.rocketlacorp.com</I>. Information contained on our website is not incorporated
by reference into this prospectus supplement, and you should not consider any information on, or that can be accessed from, our
website as part of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus supplement is part of a registration statement
we filed with the SEC. We have incorporated exhibits into the registration statement. You should read the exhibits carefully for
provisions that may be important to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have not authorized anyone to provide you with any information
other than that contained or incorporated by reference into this prospectus supplement. We are not making an offer of these securities
in any state where the offer is not permitted. You should not assume that the information in this prospectus supplement or in the
documents incorporated by reference is accurate as of any date other than the date on the front of this prospectus supplement or
those documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->








<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>PROSPECTUS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman, Times, Serif" align="center"><b>Rocket Lab USA, Inc. </b></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt" align="center">


<img src="img001.jpg" alt="LOGO">
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman, Times, Serif" align="center"><b>Common Stock </b></p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman, Times, Serif" align="center"><b>Preferred Stock </b></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman, Times, Serif" align="center"><b>Debt
Securities </b></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman, Times, Serif" align="center"><b>Warrants </b></p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman, Times, Serif" align="center"><b>Units </b></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><center>
<p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</p></center> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may from time to time offer
and sell the securities identified above in one or more offerings. In addition, selling securityholders to be named in a prospectus supplement may offer our securities from time to time. This prospectus describes the general terms of these
securities and the general manner in which these securities will be offered. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We will provide the specific terms of these securities in supplements to
this prospectus. The prospectus supplements will also describe the specific manner in which these securities will be offered and may also supplement, update or amend information contained in this document. You should read this prospectus, the
applicable prospectus supplement and any related free writing prospectus, as well the documents incorporated by reference herein and therein, before you invest. The securities may be offered by us or by selling securityholders in amounts, at prices
and on terms determined at the time of offering. The securities may be sold directly to you, through agents, or through underwriters and dealers. If agents, underwriters or dealers are used to sell the securities, we will name them and describe
their compensation in a prospectus supplement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Our common stock is listed on The Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol
&ldquo;RKLB.&rdquo; On March&nbsp;10, 2025, the closing price for our common stock, as reported on Nasdaq, was $17.12 per share. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><center>
<p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</p></center> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman, Times, Serif"><b>Investing in our securities
involves a high degree of risk. You should review carefully the risks and uncertainties referenced under the heading &ldquo;<a href="#b002_v1">Risk Factors</a>&rdquo; contained in this prospectus beginning on page 2 and any applicable prospectus
supplement, and under similar headings in the other documents that are incorporated by reference into this prospectus. </b></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Neither the Securities and
Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </b></p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><center> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</p></center>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b>The date of this prospectus is March&nbsp;11, 2025. </b></p>
</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><u><a name="toc"></a>TABLE OF CONTENTS </u></b></p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" align="center">


<tr>

<td width="97%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b001_v1">ABOUT THIS PROSPECTUS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">1</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b002_v1">RISK FACTORS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">2</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b003_v1">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">3</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b004_v1">THE COMPANY</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">5</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b005_v1">USE OF PROCEEDS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">6</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b006_v1">DESCRIPTION OF CAPITAL STOCK</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">7</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b007_v1">DESCRIPTION OF DEBT SECURITIES</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">15</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b008_v1">DESCRIPTION OF WARRANTS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">21</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b009_v1">DESCRIPTION OF UNITS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">22</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b010_v1">SELLING SECURITYHOLDERS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">25</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b011_v1">PLAN OF DISTRIBUTION</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">26</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b012_v1">LEGAL MATTERS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">29</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b013_v1">EXPERTS</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">29</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b014_v1">WHERE YOU CAN FIND MORE INFORMATION</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">29</td>
<td valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman, Times, Serif; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman, Times, Serif"><a href="#b015_v1">INCORPORATION BY REFERENCE</a></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom" align="right">30</td>
<td valign="bottom">&nbsp;</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">i </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b001_v1"></a>ABOUT THIS PROSPECTUS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">This prospectus is part of an automatic registration statement on Form <font style="white-space:nowrap">S-3</font> that we filed with the Securities and
Exchange Commission (the &ldquo;SE&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) utilizing a &ldquo;shelf&rdquo; registration process as a &ldquo;well-known seasoned issuer&rdquo;, as defined in Rule 405 under the
Securities Act. Under this shelf registration process, we and/or any selling securityholders may from time to time sell any combination of the securities described in this prospectus in one or more offerings. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">This prospectus provides you with a general description of the securities we or the selling securityholders may offer. Each time we or the selling
securityholders offer and sell securities, we or the selling securityholders will provide you with one or more prospectus supplements that will contain specific information about the terms of the offering. The prospectus supplement or a free writing
prospectus may also add, update or change information contained in this prospectus. This prospectus, together with the accompanying prospectus supplement and any related free writing prospectus, contains important information you should know before
investing in our securities, including important information about us and the securities being offered. You should read both this prospectus, the accompanying prospectus supplement and any related free writing prospectus together with the additional
information described under the heading &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation by Reference&rdquo; elsewhere in this prospectus. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Neither we nor any selling securityholder have authorized anyone to provide you with different or additional information from that set forth in this
prospectus, any accompanying prospectus supplement and any related free writing prospectus. We do not take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus and
any accompanying prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the securities described in this prospectus or such accompanying prospectus supplement or an offer to sell or
the solicitation of an offer to buy such securities in any circumstances in which such offer or solicitation is unlawful. You should assume that the information appearing in this prospectus, any prospectus supplement, the documents incorporated by
reference herein or therein and any related free writing prospectus is accurate only as of their respective dates, regardless of the time of delivery of this prospectus, any applicable prospectus supplement or any sale of securities. Our business,
financial condition, results of operations and prospects may have changed materially since those dates. This prospectus, any applicable prospectus supplement and the information incorporated by reference herein or therein may contain market data,
industry statistics and other data that have been obtained or compiled from information made available by independent third parties. We have not independently verified the accuracy and completeness of such data. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Unless the context otherwise indicates, references in this prospectus to &ldquo;Rocket Lab&rdquo;, &ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;us&rdquo; refer,
collectively, to Rocket Lab USA, Inc., a Delaware corporation, and its consolidated subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We use various trademarks and trade names in our
business, including without limitation our corporate name and logo. All other trademarks or trade names referred to in this prospectus are the property of their respective owners. Solely for convenience, the trademarks and trade names in this
prospectus may be referred to without the <sup style="font-size:75%; vertical-align:top">&#64;</sup> and <sup style="font-size:75%; vertical-align:top">&trade;</sup> symbols, but such references should not be construed as any indicator that their
respective owners will not assert, to the fullest extent under applicable law, their rights thereto. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">1 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b002_v1"></a>RISK FACTORS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Investing in our securities involves significant risks. Please see the risk factors under the heading &ldquo;Risk Factors&rdquo; in our most recent Annual
Report on Form <font style="white-space:nowrap">10-K</font> , as well as any risk factors included in our Quarterly Reports on Form <font style="white-space:nowrap">10-Q,</font> our Current Reports on Form
<font style="white-space:nowrap">8-K,</font> and the other documents we file with the SEC that are incorporated by reference in this prospectus, along with any risk factors identified in a prospectus supplement or any applicable free writing
prospectus. Before making an investment decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this prospectus and any prospectus supplement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The risks and uncertainties we have described are not the only ones facing our company. Additional risks and uncertainties not presently known to us or that
we currently deem immaterial may also affect our business operations. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities. The discussion of risks includes or refers to
forward-looking statements. You should read the explanation of the qualifications and limitations on such forward-looking statements discussed elsewhere in this prospectus. Actual results could differ materially from those anticipated in these
forward-looking statements as a result of certain factors, including the risks referenced below and described in the documents incorporated herein by reference. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">2 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b003_v1"></a>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">This prospectus, including the documents that we incorporate by reference, contains forward-looking statements within the meaning of Section&nbsp;27A of the
Securities Act and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Our forward-looking statements include, but are not limited to, statements regarding our or our management team&rsquo;s
expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are
forward-looking statements. The words &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;could,&rdquo; &ldquo;expect,&rdquo; &ldquo;intends,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo;
&ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;would&rdquo; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking
statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking
statements. Forward-looking statements in this report may include, for example, statements about: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">Our ability to effectively manage future growth and achieve operational efficiencies; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any inability of us to operate our Electron Launch Vehicle (&ldquo;Electron&rdquo;) at its anticipated launch rate,
including due to any government action related to launch failure and our ability to operate, could adversely impact our business, financial condition and results of operations; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">our inability to develop our Neutron Launch Vehicle (&ldquo;Neutron&rdquo;) or significant delays in developing
Neutron could adversely impact our business, financial condition and results of operations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">our inability to utilize our launch pads at our private launch complex in Mahia, New Zealand or at NASA&rsquo;s
Wallops Flight Facility, at Wallops Island, Virginia with sufficient frequency to support our launch cadence and future related revenue growth expectations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">our spacecraft, space systems or space system components failing to operate as intended could have a material
adverse effect on our business, financial condition and results of operations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">changes in the competitive and highly regulated industries in which we operate, variations in operating
performance across competitors, changes in laws and regulations affecting our business and changes in our capital structure; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">changes in governmental policies, priorities, regulations, mandates or funding for programs in which we or our
customers participate, which could negatively impact our business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">loss of, or default by, one or more of our key customers or inability of customers to fund contractual
commitments, which could result in a decline in future revenues, cancellation of contracted launches or space systems orders or termination or default of existing agreements; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the inability to comply with, and costs associated with complying, any applicable regulations, and specifically,
U.S. government contract regulations, which could result in loss of contract opportunities, contract modifications or termination, assessment of penalties and fines, and suspension or debarment from U.S. government contracting or subcontracting;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">success in retaining or recruiting, or changes required in, officers, key employees or directors, and our ability
to attract and retain key personnel, including Peter Beck, our President, Chief Executive Officer and Chairman; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">defects in or failure of our products to operate in the expected manner, including any launch failure, which
could result in a loss of revenue, impact our business, prospects and profitability, increase our insurance rates and damage our reputation and ability to obtain future customers; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">inability or failure to protect intellectual property; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">disruptions in the supply of key raw materials or components used to produce our products or increases in prices
of raw materials; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">3 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the ability to implement our business plans, forecasts and other expectations, including the integration of
recently acquired businesses, and to identify and realize additional opportunities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the diversion of management&rsquo;s attention and consumption of resources as a result of acquisitions of other
companies and success in integrating and otherwise achieving the benefits of recent and potential acquisitions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">our inability to effectively integrate or benefit from recently purchased assets or businesses;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">global inflation and interest rates; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">impacts of the war in Ukraine or Israel or other global conflicts; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">fluctuations in foreign exchange rates; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the risk of downturns in government and commercial launch services and spacecraft industries;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">our ability to anticipate changes in the markets for rocket launch services, mission services, spacecraft and
spacecraft components; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the inability or failure to comply with contractual requirements or covenants; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">failure to maintain adequate operational and financial resources or raise additional capital or generate
sufficient cash flows; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any significant disruption in or unauthorized access to our computer systems or those of third parties that we
utilize in our operations, including those relating to cybersecurity or arising from cyber-attacks; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">other factors detailed under the section of this prospectus titled &ldquo;Risk Factors.&rdquo;
</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may
vary in material respects from those projected in these forward-looking statements. Some of these risks and uncertainties may in the future be amplified by a global crises and/or any response to such a crisis and there may be additional risks that
we consider immaterial or which are unknown. It is not possible to predict or identify all such risks. It is not possible to predict or identify all such risks. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The forward-looking statements contained in this prospectus are based on information available to us at the time of this prospectus and current expectations,
forecasts, assumptions and beliefs concerning future developments and their potential effects, and involve a number of judgments, risks and uncertainties. There can be no assurance that future developments affecting us will be those that we have
anticipated. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after
the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">4 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b004_v1"></a>THE COMPANY </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Our Mission: We Open Access to Space to Improve Life on Earth. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Rocket Lab is an <font style="white-space:nowrap"><font style="white-space:nowrap">end-to-end</font></font> space company with an established track record of
mission success. We deliver reliable launch services, spacecraft design services, spacecraft components, spacecraft manufacturing and other spacecraft and <font style="white-space:nowrap">on-orbit</font> management solutions that make it faster,
easier and more affordable to access space. We believe that space has defined some of humanity&rsquo;s greatest achievements and it continues to shape our future. We are motivated by the impact we can have on Earth by making it easier to get to space
and to use it as a platform for innovation, exploration and infrastructure. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We design and manufacture small and medium-class rockets, spacecraft and
spacecraft components and related software and services to support the space economy. Our launch services are used to place spacecraft into Earth orbit and escape trajectories, and utilize orbital launch vehicles that place payloads into a variety
of planes/inclinations and altitude trajectories. Our space systems solutions are the building blocks for spacecraft, which includes composite structures, reaction wheels, star trackers, solar power solutions, radios, separation systems, and command
and control spacecraft software. Our family of spacecraft product lines is configurable for a range of low Earth orbit, medium Earth orbit, geosynchronous orbit and interplanetary missions. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Our corporate headquarters are located at 3881 McGowen Street, Long Beach, California 90808, and our telephone number is (714)
<font style="white-space:nowrap">465-5737.</font> Our website is located at www.rocketlabusa.com. We do not incorporate the information on or accessible through our website into this prospectus, and you should not consider any information on, or
that can be accessed through, our website as part of this prospectus. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">5 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b005_v1"></a>USE OF PROCEEDS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement. We will not receive any proceeds from
the sale of securities by selling securityholders. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">6 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b006_v1"></a>DESCRIPTION OF CAPITAL STOCK </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><i>The following description of our common stock and preferred stock, together with the additional information we include in any applicable prospectus
supplements, summarizes the material terms and provisions of the common stock and preferred stock that we may offer under this prospectus. The following description of our capital stock does not purport to be complete and is subject to, and
qualified in its entirety by, our amended and restated certificate of incorporation (the &ldquo;Certificate of Incorporation&rdquo;), our amended and restated bylaws (the &ldquo;Bylaws&rdquo;) and the certificate of designation for the Series A
Preferred Stock (the &ldquo;Certificate of Designation&rdquo;), which are exhibits to the registration statement of which this prospectus forms a part, and by applicable law. The terms of our common stock and preferred stock may also be affected by
Delaware law. </i></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Authorized Capital Stock </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The
Certificate of Incorporation authorizes the issuance of 2,500,000,000 shares of common stock, $0.0001 par value per share and 100,000,000 shares of preferred stock, $0.0001 par value. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Common Stock </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Voting rights </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Each share of our common stock entitles the holder thereof to one vote on all matters submitted to a vote of the shareholders, including the election of
directors, and does not have cumulative voting rights. Accordingly, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Dividend rights </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Subject to preferences that may
be applicable to any then outstanding preferred stock, the holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our Board of Directors (the &ldquo;Board&rdquo;) out of legally available funds.
</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Rights upon liquidation </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">In the event of our
liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to shareholders after the payment of all of our debts and other liabilities, subject to the
satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Other rights </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">No holders of our common stock will be entitled to preemptive, conversion, or subscription rights contained in the Certificate of Incorporation or Bylaws.
There are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences, and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of
any series of preferred stock that may be designated and issued in the future. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Preferred Stock </b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>General </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Under the Certificate of Incorporation,
the Board has the authority, without further action by the stockholders, to issue up to 100,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the
rights, preferences, and privileges of the shares of each </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">7 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">
wholly unissued series and any qualifications, limitations, or restrictions thereon and to increase or decrease the number of shares of any such series, but not below the number of shares of such
series then outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The Board may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying,
deferring or preventing a change in our control that may otherwise benefit holders of our common stock and may adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">A prospectus supplement relating to any series of preferred stock being offered will include specific terms relating to the offering. They will include, where
applicable: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the title and stated value; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">he number of shares we are offering; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the liquidation preference per share; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the purchase price; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the dividend rate, period and payment date and method of calculation for dividends; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">whether dividends will be cumulative or <font style="white-space:nowrap">non-cumulative</font> and, if
cumulative, the date from which dividends will accumulate; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the procedures for any auction and remarketing, if any; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the provisions for a sinking fund, if any; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those
redemption and repurchase rights; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any listing of the preferred stock on any securities exchange or market; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">whether the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price, or
how it will be calculated, and the exchange period; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">voting rights, if any, of the preferred stock; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">preemptive rights, if any; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">restrictions on transfer, sale or other assignment, if any; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">whether interests in the preferred stock will be represented by depositary shares; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">a discussion of any material United States federal income tax considerations applicable to the preferred stock;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate,
dissolve or wind up our affairs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any limitations on the issuance of any class or series of preferred stock ranking senior to or on a parity with
the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.
</p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Series A Preferred Stock </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">On December&nbsp;3, 2024, we entered into an exchange agreement with The Equatorial Trust (the &ldquo;Trust&rdquo;), a family trust established by Sir Peter Beck
(&ldquo;Sir Peter&rdquo;), our Founder, President, Chief Executive Officer and Chairman, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">8 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">
to exchange 50,951,250 shares of our common stock into 50,951,250 shares of our Series A Convertible Participating Preferred Stock, $0.0001 par value per share (the &ldquo;Series A Preferred
Stock&rdquo;). On January&nbsp;7, 2025, the exchange was consummated and we filed the Certificate of Designation with the Secretary of State of the State of Delaware, which became effective upon filing. At the Closing, we issued 50,951,250 shares of
Series A Preferred Stock to the Trust. The terms of the Series A Preferred Stock are described in further detail below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Conversion Rights;
Conversion Rate Adjustments </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Pursuant to the terms of the Certificate of Designation, each share of Series A Preferred Stock will be convertible at
any time at the option of the holder of the Series A Preferred Stock (a &ldquo;Holder&rdquo;) into a number of shares of common stock at the then-applicable conversion rate (the &ldquo;Conversion Rate&rdquo;). In addition, each share of Series A
Preferred Stock will automatically convert into a number of shares of common stock at the Conversion Rate upon the earliest to occur of (a)&nbsp;a transfer of such share (other than to a Permitted Transferee), (b) the first date on which Sir Peter
no longer serves as (i)&nbsp;our Chief Executive Officer or (ii)&nbsp;such other executive officer position of us as approved by the Board, (c)&nbsp;Sir Peter&rsquo;s death or permanent disability, or (d)&nbsp;the first date on which the outstanding
shares of Series A Preferred Stock no longer represent a minimum beneficial ownership by Sir Peter of five percent. A &ldquo;Permitted Transferee&rdquo; is defined in the Certificate of Designation and includes Sir Peter and his controlled affiliates.
The Series A Series A Preferred Stock is not redeemable by us at any time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The initial Conversion Rate for each share of Series A Preferred Stock is one
share of common stock, and is subject to adjustment, including for stock dividends, distributions, stock splits and stock combinations. In addition, if we (a)&nbsp;issue securities entitling the holder thereof to acquire common stock or
(b)&nbsp;declare or make any dividend or other distribution of our assets, a Holder will be entitled to participate to the same extent if the Holder had held the number of shares of common stock acquirable upon conversion of such Holder&rsquo;s
Series A Preferred Stock. The Certificate of Designation also contains customary protections in the event of changes in common stock as a result of certain fundamental change transactions. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Director Designation Right </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The Certificate of
Designation provides that, so long as any shares of Series A Preferred Stock are outstanding, the Holders, voting exclusively and as a separate class, will be entitled to designate and elect at least one individual to serve on the Board as a
director (a &ldquo;Series A Preferred Stock Director&rdquo;). The initial Series A Preferred Stock Director is Sir Peter. Sir Peter will serve an initial term that expires at our annual meeting of stockholders in 2027. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">In the event the Board increases its size to more than ten members, the Holders will be entitled to designate and elect, voting exclusively and as a separate
class, one or more additional Series A Preferred Stock Directors in order to maintain the right to elect ten percent of the total number of authorized directorships, rounded up to the nearest whole number. Additional Series A Preferred Stock
Directors will serve for an initial term fixed by the Board. After the initial term of a Series A Preferred Stock Director has expired, his or her successor shall be elected for a term expiring at the third annual meeting following his or her
election, unless such term expires sooner. A Series A Preferred Stock Director will serve until the earlier of: (a)&nbsp;his or her successor being elected and qualified, (b)&nbsp;his or her earlier death, disability, retirement, resignation or
removal or (c)&nbsp;such time as the size of the Board is automatically reduced. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">To be eligible for election as a Series A Preferred Stock Director, a
nominee (other than Sir Peter) must: (a)&nbsp;satisfy all requirements regarding service as a director of us under applicable law and regulation and our bylaws, (b)&nbsp;not be an immediate family member of Sir Peter or any Holder, (c)&nbsp;be
independent of each Holder, and (d)&nbsp;have served on the board of directors of at least one publicly traded corporation, in the United States or elsewhere, within the last five years, or is otherwise well qualified in the reasonable judgment of
the Board. The Series A Preferred Stock Director may be removed at any time as a director on the Board (without cause) upon the written request of the Holders by the affirmative vote of the holders of at least a majority of the outstanding
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">9 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">
shares of Series A Preferred Stock at the time and with each share of Series A Preferred Stock entitled to one vote. At the first annual meeting of our stockholders held after such time as there
are no shares of Series A Preferred Stock outstanding, the director designation and election rights will terminate. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Dividends </i></b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The Series A Preferred Stock is not entitled to any scheduled dividend payments. Holders will be entitled to receive dividends on shares of Series A Preferred
Stock equal (on an <font style="white-space:nowrap"><font style="white-space:nowrap"><font style="white-space:nowrap"><font style="white-space:nowrap">as-if-converted-to-Common-Stock</font></font></font></font> basis) to, and in the same form as
dividends actually paid on, all or substantially all of the shares of common stock when, as and if such dividends (other than dividends in the form of common stock) are paid on shares of the common stock, subject to certain exceptions specified in
the Certificate of Designation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Liquidation Preference </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Upon any liquidation, dissolution or <font style="white-space:nowrap">winding-up</font> of us, whether voluntary or involuntary, after the satisfaction in full
of our debts and the payment of any liquidation preference ranking senior to the Series A Preferred Stock, Holders will be entitled to receive an amount equal to $0.0001 per share of Series A Preferred Stock. Following the payment of the full amount
of the liquidation preference in respect of all outstanding shares of Series A Preferred Stock, Holders participate pari passu with the holders of the common stock (on an <font style="white-space:nowrap"><font style="white-space:nowrap"><font style="white-space:nowrap"><font style="white-space:nowrap">as-if-converted-to-common-stock</font></font></font></font> basis) in our net assets. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Voting and Consent Rights </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The Series A Preferred
Stock will have the right to vote on all matters submitted for a vote of the holders of the common stock, voting together as a single class with the common stock. Each Holder will be entitled to cast a number of votes per share equal to the number
of shares of common stock into which a share of Series A Preferred Stock is convertible. In addition, we may not, without the affirmative vote of the Holders of a majority of the then outstanding shares of Series A Preferred Stock: (a)&nbsp;alter,
amend or repeal any provision of our Certificate of Incorporation if it would alter or change the powers, preferences or special rights of the Series A Preferred Stock so as to affect them adversely, (b)&nbsp;alter, amend, or repeal the Certificate
of Designation, or (c)&nbsp;increase the authorized number of shares of Series A Preferred Stock or authorize the issuance of additional shares of Series A Preferred Stock. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Election of Directors and Vacancies </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Subject to the
rights of any series of preferred stock then outstanding to elect additional directors under specified circumstances, the directors on the Board will be divided, with respect to the time for which they severally hold office, into three classes
designated as Class&nbsp;I, Class&nbsp;II and Class&nbsp;III, respectively. At each annual meeting of stockholders, directors elected to succeed those directors whose terms expire shall be elected for a term of office to expire at the third
succeeding annual meeting of stockholders after their election. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Under the Bylaws, except as may be required in the Certificate of Incorporation,
directors shall be elected by a plurality of the votes cast by the holders of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Each director shall hold office until the annual meeting at which such director&rsquo;s term expires and until such director&rsquo;s successor is elected and
qualified or until such director&rsquo;s earlier death, resignation, or removal. Subject to the rights of holders of any series of preferred stock to elect directors, directors may be removed only as provided by the Certificate of Incorporation and
applicable law. All vacancies occurring on the Board and any newly created directorships resulting from any increase in the authorized number of directors shall be filled in the manner set forth below. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">10 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Subject to the rights, if any, of the holders of any series of preferred stock then outstanding to elect
directors and to fill vacancies in the Board relating thereto, any and all vacancies in the Board, however occurring, including, without limitation, by reason of an increase in the size of the Board, or the death, resignation, disqualification or
removal of a director, shall be filled solely and exclusively by the affirmative vote of a majority of the remaining directors then in office, even if less than a quorum of the Board, and not by the stockholders. Any director appointed in accordance
with the preceding sentence shall hold office for the remainder of the full term of the class of directors in which the new directorship was created or the vacancy occurred and until such director&rsquo;s successor shall have been duly elected and
qualified or until his or her earlier resignation, death or removal. Subject to the rights, if any, of the holders of any series of preferred stock then outstanding to elect directors, when the number of directors is increased or decreased, the
Board shall, subject to the Certificate of Incorporation, determine the class or classes to which the increased or decreased number of directors shall be apportioned; provided, however, that no decrease in the number of directors shall shorten the
term of any incumbent director. In the event of a vacancy in the Board, the remaining directors, except as otherwise provided by law, shall exercise the powers of the full Board until the vacancy is filled. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Quorum </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Except as otherwise provided by applicable law,
the Certificate of Incorporation or the Bylaws, at each meeting of stockholders the holders of a majority of the voting power of the shares of stock issued and outstanding and entitled to vote at the meeting, present in person or represented by
proxy, shall constitute a quorum for the transaction of business. If less than a quorum is present at a meeting, the stockholders representing a majority of the voting power present at the meeting or the presiding officer may adjourn the meeting
from time to time, and the meeting may be held as adjourned without further notice. At such adjourned meeting at which a quorum is present, any business may be transacted which might have been transacted at the original meeting. The stockholders
present at a duly constituted meeting may continue to transact business until adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Listing of Securities </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Our common stock is listed on
Nasdaq under the symbol &ldquo;RKLB.&rdquo; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Transfer Agent and Registrar </b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The transfer agent and registrar for the common stock is Equiniti Trust Company, LLC. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Anti-takeover Effects of the Certificate of Incorporation and the Bylaws </b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The Certificate of Incorporation and the Bylaws contain provisions that may delay, defer or discourage another party from acquiring control of our Company. We
expect that these provisions, which are summarized below, will discourage coercive takeover practices or inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of our Company to first negotiate
with our Board, which we believe may result in an improvement of the terms of any such acquisition in favor of our stockholders. However, they also give the board of directors the power to discourage acquisitions that some stockholders may favor.
</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Authorized but Unissued Capital Stock </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of Nasdaq, which would apply so
long as our common stock remains listed on Nasdaq, require stockholder approval of certain issuances equal to or exceeding 20% of the then outstanding voting power or then outstanding number of shares of our common stock. Additional shares that may
be issued in the future may be used for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">11 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">One of the effects of the existence of unissued and unreserved common stock may be to enable our Board to
issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of our Company by means of a merger, tender offer, proxy contest or otherwise and thereby protect the
continuity of management and possibly deprive stockholders of opportunities to sell their shares of common stock at prices higher than prevailing market prices. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Special Meeting, Action by Written Consent and Advance Notice Requirements for Stockholder Proposals </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The Certificate of Incorporation provides that holders of our common stock may not take action by written consent, but may only take action at annual or
special meetings of our stockholders. As a result, a holder controlling a majority of our capital stock would not be able to amend the Bylaws or remove directors without holding a meeting of our stockholders called in accordance with the Bylaws. The
Bylaws further provide that special meetings of our stockholders may be called only by a majority of our Board, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force
consideration of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The
Bylaws provide for advance notice procedures for stockholders seeking to bring business before an annual meeting of stockholders or to nominate candidates for election as directors at an annual meeting of stockholders. The Bylaws also specify
certain requirements regarding the form and content of a stockholder&rsquo;s notice. These provisions might preclude stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at the annual
meeting of stockholders if the proper procedures are not followed. We expect that these provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&rsquo;s own slate of directors or
otherwise attempting to obtain control of our company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Amendment to Certificate of Incorporation and Bylaws </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may amend or repeal any provision contained in the Certificate of Incorporation in the manner prescribed by the laws of the State of Delaware, and all
rights conferred upon stockholders are granted subject to this reservation. Notwithstanding any provision of the Certificate of Incorporation or any provision of law that might otherwise permit a lesser vote or no vote, subject to the rights of any
outstanding series of preferred stock, but in addition to any vote of the holders of any class or series of our stock required by law, (i)&nbsp;the affirmative vote of the holders of at least <font style="white-space:nowrap">sixty-six</font> and <font style="white-space:nowrap">two-thirds</font> percent <font style="white-space:nowrap">(66-2/3%)</font> of the voting power of all of the then-outstanding shares of our capital stock entitled to vote on such amendment, voting together as a single
class, and (ii)&nbsp;the affirmative vote of not less than <font style="white-space:nowrap">sixty-six</font> and <font style="white-space:nowrap">two-thirds</font> percent <font style="white-space:nowrap">(66-2/3%)</font> of the voting power of the
outstanding shares of each class entitled to vote thereon as a class will be required to amend or repeal certain provisions of the Certificate of Incorporation. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Our Board shall have the power to adopt, amend or repeal the Bylaws. Any adoption, amendment or repeal of the Bylaws by our Board shall require the approval
of a majority of the directors on our Board. The stockholders shall also have power to adopt, amend or repeal the Bylaws. Notwithstanding any other provision of the Certificate of Incorporation or any provision of law that might otherwise permit a
lesser or no vote, but in addition to any vote of the holders of any class or series of our stock required by applicable law or by the Certificate of Incorporation, the affirmative vote of the holders of at least
<font style="white-space:nowrap">sixty-six</font> and <font style="white-space:nowrap">two-thirds</font> percent <font style="white-space:nowrap">(66-2/3%)</font> of the voting power of all of the then-outstanding shares of our capital stock
entitled to vote on such amendment, voting together as a single class, shall be required for the stockholders to adopt, amend or repeal any provision of the Bylaws, provided that, if our Board recommends that the holders of our capital stock approve
any amendment or repeal of the Bylaws at a meeting of stockholders, such amendment or repeal shall only require the affirmative vote of the majority of the outstanding shares of our capital stock entitled to vote on such amendment or repeal, voting
together as a single class. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">12 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Delaware Anti-Takeover Statute </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Section&nbsp;203 of the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;) provides that if a person acquires 15% or more of the voting stock of a
Delaware corporation, such person becomes an &ldquo;interested stockholder&rdquo; and may not engage in certain &ldquo;business combinations&rdquo; with the corporation for a period of three years from the time such person acquired 15% or more of the
corporation&rsquo;s voting stock, unless: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman, Times, Serif">(1) the board of directors approves the acquisition of stock resulting in such person becoming an
interested stockholder or the business combination before the time that the person becomes an interested stockholder; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman, Times, Serif">(2) upon
consummation of the transaction resulting in such person becoming an interested stockholder, the interested stockholder owns at least 85% of the outstanding voting stock of the corporation at the time the business combination commences (excluding
voting stock owned by directors who are also officers and certain employee stock plans); or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman, Times, Serif">(3) the business combination is approved by
the board of directors and at a meeting of stockholders, not by written consent, by the affirmative vote of 2/3 of the outstanding voting stock which is not owned by the interested stockholder. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Limitations on Liability and Indemnification of Officers and Directors </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Section&nbsp;145 of the DGCL authorizes a court to award, or a corporation&rsquo;s board of directors to grant, indemnity to directors and officers under
certain circumstances and subject to certain limitations. The terms of Section&nbsp;145 of the DGCL are sufficiently broad to permit indemnification under certain circumstances for liabilities, including reimbursement of expenses incurred, arising
under the Securities Act. As permitted by the DGCL, our Certificate of Incorporation contains provisions that eliminate the personal liability of directors for monetary damages for any breach of fiduciary duties as a director, except liability for
the following (i)&nbsp;any breach of a director&rsquo;s duty of loyalty to us or our stockholders; (ii)&nbsp;acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; (iii)&nbsp;under Section&nbsp;174
of the DGCL; or (iv)&nbsp;any transaction from which the director derived an improper personal benefit. As permitted by the DGCL, the Bylaws provide that: (i)&nbsp;we are required to indemnify its directors and executive officers to the fullest
extent permitted by the DGCL, subject to very limited exceptions; (ii)&nbsp;we may indemnify our other employees and agents as set forth in the DGCL; (iii)&nbsp;we are required to advance expenses, as incurred, to its directors and executive
officers in connection with a legal proceeding to the fullest extent permitted by the DGCL, subject to very limited exceptions; and (iv)&nbsp;the rights conferred in the Bylaws are not exclusive. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We have entered into indemnification agreements with each director and executive officer to provide these individuals additional contractual assurances
regarding the scope of the indemnification set forth in the Certificate of Incorporation and Bylaws and to provide additional procedural protections. There is no pending litigation or proceeding involving one of our directors or executive officers
for which indemnification is sought. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The indemnification provisions in the Certificate of Incorporation, Bylaws, and the indemnification agreements
entered into or to be entered into between us and each of its directors and executive officers may be sufficiently broad to permit indemnification of our directors and executive officers for liabilities arising under the Securities Act. We currently
carries liability insurance for our directors and officers. Certain of our directors are also indemnified by their employers with regard to service on our Board. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to
the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">13 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Exclusive Jurisdiction of Certain Actions </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The Certificate of Incorporation requires, to the fullest extent permitted by law, unless we consent in writing to the selection of an alternative forum, that
the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any state law claims for: (i)&nbsp;any derivative action or proceeding brought on behalf of us; (ii)&nbsp;any action asserting a claim of breach of a fiduciary
duty owed by any current or former director, officer, or other employee of ours to us or our stockholders; (iii)&nbsp;any action asserting a claim against us or any current or former director, officer or other employee or stockholder of ours arising
pursuant to any provision of the DGCL or the Certificate of Incorporation or the Bylaws; or (iv)&nbsp;any action asserting a claim against us or any current or former director, officer or other employee or stockholder of ours governed by the
internal affairs doctrine. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">In addition, the Certificate of Incorporation requires that, unless we consent in writing to the selection of an alternative
forum, the federal district courts of United States shall be the sole and exclusive forum for resolving any action asserting a claim arising under the Securities Act.</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">14 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b007_v1"></a>DESCRIPTION OF DEBT SECURITIES </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may offer debt securities which may be senior or subordinated. We refer to the senior debt securities and the subordinated debt securities collectively as
debt securities. Each series of debt securities may have different terms. The following description summarizes the general terms and provisions of the debt securities. We will describe the specific terms of the debt securities and the extent, if
any, to which the general provisions summarized below apply to any series of debt securities in the prospectus supplement relating to the series and any applicable free writing prospectus that we authorize to be delivered. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may issue senior debt securities from time to time, in one or more series under a senior indenture to be entered into between us and a senior trustee to be
named in a prospectus supplement, which we refer to as the senior trustee. We may issue subordinated debt securities from time to time, in one or more series, under a subordinated indenture to be entered into between us and a subordinated trustee to
be named in a prospectus supplement, which we refer to as the subordinated trustee. The forms of senior indenture and subordinated indenture are filed as exhibits to the registration statement of which this prospectus forms a part. Together, the
senior indenture and the subordinated indenture are referred to as the indentures and, together, the senior trustee and the subordinated trustee are referred to as the trustees. This prospectus briefly outlines some of the provisions of the
indentures. The following summary of the material provisions of the indentures is qualified in its entirety by the provisions of the indentures, including definitions of certain terms used in the indentures. Wherever we refer to particular sections
or defined terms of the indentures, those sections or defined terms are incorporated by reference in this prospectus or the applicable prospectus supplement. You should review the indentures that are filed as exhibits to the registration statement
of which this prospectus forms a part for additional information. As used in this prospectus, the term &ldquo;debt securities&rdquo; includes the debt securities being offered by this prospectus and all other debt securities issued by us under the
indentures. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>General </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The indentures: </p>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">do not limit the amount of debt securities that we may issue; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">allow us to issue debt securities in one or more series; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">do not require us to issue all of the debt securities of a series at the same time; and </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">allow us to reopen a series to issue additional debt securities without the consent of the holders of the debt
securities of such series. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Unless otherwise provided in the applicable prospectus supplement, the senior debt securities will be
unsubordinated obligations and will rank equally with all of our other unsecured and unsubordinated indebtedness. Payments on the subordinated debt securities will be subordinated to the prior payment in full of all of our senior indebtedness, as
described under the section titled &ldquo;&mdash;Subordination&rdquo; and in the applicable prospectus supplement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Each indenture provides that we may, but
need not, designate more than one trustee under an indenture. Any trustee under an indenture may resign or be removed and a successor trustee may be appointed to act with respect to the series of debt securities administered by the resigning or
removed trustee. If two or more persons are acting as trustee with respect to different series of debt securities, each trustee shall be a trustee of a trust under the applicable indenture separate and apart from the trust administered by any other
trustee. Except as otherwise indicated in this prospectus, any action described in this prospectus to be taken by each trustee may be taken by each trustee with respect to, and only with respect to, the one or more series of debt securities for
which it is trustee under the applicable indenture. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The prospectus supplement for each offering will provide the following terms, where applicable: </p>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the title of the debt securities and whether they are senior or subordinated; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">15 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any limit upon the aggregate principal amount of the debt securities of that series; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the date or dates on which the principal of the debt securities of the series is payable; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the price at which the debt securities will be issued, expressed as a percentage of the principal and, if other
than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity thereof or, if applicable, the portion of the principal amount of such debt securities that is convertible into
another security of ours or the method by which any such portion shall be determined; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the rate or rates at which the debt securities of the series shall bear interest or the manner of calculation of
such rate or rates, if any; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the date or dates from which interest will accrue, the interest payment dates on which such interest will be
payable or the manner of determination of such interest payment dates, the place(s) of payment, and the record date for the determination of holders to whom interest is payable on any such interest payment dates or the manner of determination of
such record dates; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the right, if any, to extend the interest payment periods and the duration of such extension;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the period or periods within which, the price or prices at which and the terms and conditions upon which debt
securities of the series may be redeemed, converted or exchanged, in whole or in part; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">our obligation, if any, to redeem or purchase debt securities of the series pursuant to any sinking fund,
mandatory redemption, or analogous provisions (including payments made in cash in satisfaction of future sinking fund obligations) or at the option of a holder thereof and the period or periods within which, the price or prices at which, and the
terms and conditions upon which, debt securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the form of the debt securities of the series including the form of the Certificate of Authentication for such
series; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">if other than minimum denominations of one thousand U.S. dollars ($1,000) or any integral multiple of $1,000
thereof, the denominations in which the debt securities of the series shall be issuable; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">whether the debt securities of the series shall be issued in whole or in part in the form of a global debt
security or global debt securities; the terms and conditions, if any, upon which such global debt security or global debt securities may be exchanged in whole or in part for other individual debt securities; and the depositary for such global debt
security or global debt securities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">whether the debt securities will be convertible into or exchangeable for common stock or other securities of ours
or any other Person and, if so, the terms and conditions upon which such debt securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any
mandatory or optional (at our option or the holders&rsquo; option) conversion or exchange features, and the applicable conversion or exchange period; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any additional or alternative events of default to those set forth in the indenture; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any additional or alternative covenants to those set forth in the indenture; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the currency or currencies including composite currencies, in which payment of the principal of (and premium, if
any) and interest, if any, on such debt securities shall be payable (if other than the currency of the United States of America), which unless otherwise specified shall be the currency of the United States of America as at the time of payment is
legal tender for payment of public or private debts; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">if the principal of (and premium, if any), or interest, if any, on such debt securities is to be payable, at our
election or at the election of any holder thereof, in a coin or currency other than that in which such debt securities are stated to be payable, then the period or periods within which, and the terms and conditions upon which, such election may be
made; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">16 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">whether interest will be payable in cash or additional debt securities at our or the holders&rsquo; option and the
terms and conditions upon which the election may be made; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the terms and conditions, if any, upon which we will pay amounts in addition to the stated interest, premium, if
any and principal amounts of the debt securities of the series to any holder that is not a &ldquo;United States person&rdquo; for federal tax purposes; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">additional or alternative provisions, if any, related to defeasance and discharge of the offered debt securities
than those set forth in the indenture; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the applicability of any guarantees; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any restrictions on transfer, sale or assignment of the debt securities of the series; and </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any other terms of the debt securities (which may supplement, modify or delete any provision of the indenture
insofar as it applies to such series). </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may issue debt securities that provide for less than the entire principal amount thereof to
be payable upon declaration of acceleration of the maturity of the debt securities. We refer to any such debt securities throughout this prospectus as &ldquo;original issue discount securities.&rdquo; </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We will provide you with more information in the applicable prospectus supplement regarding any deletions, modifications, or additions to the events of
default or covenants that are described below, including any addition of a covenant or other provision providing event risk or similar protection. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Payment </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Unless otherwise provided in the applicable
prospectus supplement, the principal of, and any premium or make-whole amount, and interest on, any series of the debt securities will be payable by mailing a check to the address of the person entitled to it as it appears in the applicable register
for the debt securities or by wire transfer of funds to that person at an account maintained within the United States. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">All monies that we pay to a paying
agent or a trustee for the payment of the principal of, and any premium, or interest on, any debt security will be repaid to us if unclaimed at the end of two years after the obligation underlying payment becomes due and payable. After funds have
been returned to us, the holder of the debt security may look only to us for payment, without payment of interest for the period which we hold the funds. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Merger, Consolidation or Sale of Assets </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The indentures
provide that we may, without the consent of the holders of any outstanding debt securities, (i)&nbsp;consolidate with, (ii)&nbsp;sell, lease or convey all or substantially all of our assets to, or (iii)&nbsp;merge with or into, any other entity
provided that: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">either we are the continuing entity, or the successor entity, if other than us, assumes the obligations
(a)&nbsp;to pay the principal of, and any premium, and interest on, all of the debt securities and (b)&nbsp;to duly perform and observe all of the covenants and conditions contained in the applicable indenture; and in the event the debt securities
are convertible into or exchangeable for common stock or other securities of ours, such successor entity will, by such supplemental indenture, make provision so that the holders of debt securities of that series shall thereafter be entitled to
receive upon conversion or exchange of such debt securities the number of securities or property to which a holder of the number of common stock or other securities of ours deliverable upon conversion or exchange of those debt securities would have
been entitled had such conversion or exchange occurred immediately prior to such consolidation, merger, sale, conveyance, transfer or other disposition; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">an officers&rsquo; certificate and legal opinion covering such conditions are delivered to each applicable
trustee. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">17 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Events of Default, Notice and Waiver </b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Unless the applicable prospectus supplement states otherwise, when we refer to &ldquo;events of default&rdquo; as defined in the indentures with respect to any
series of debt securities, we mean: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">default in the payment of any installment of interest on any debt security of such series continuing for 90 days
unless such date has been extended or deferred; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">default in the payment of principal of, or any premium on, any debt security of such series when due and payable
unless such date has been extended or deferred; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">default in the performance or breach of any covenant or warranty in the debt securities or in the indenture by us
continuing for 90 days after written notice described below; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">bankruptcy, insolvency or reorganization, or court appointment of a receiver, liquidator or trustee of us; and
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any other event of default provided with respect to a particular series of debt securities.
</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">If an event of default (other than an event of default described in the fourth bullet point above) occurs and is continuing with
respect to debt securities of any series outstanding, then the applicable trustee or the holders of 25% or more in principal amount of the debt securities of that series will have the right to declare the principal amount of, and accrued interest
on, all the debt securities of that series to be due and payable. If an event of default described in the fourth bullet point above occurs, the principal amount of, and accrued interest on, all the debt securities of that series will automatically
become and will be immediately due and payable without any declaration or other act on the part of the trustee or the holders of the debt securities. However, at any time after such a declaration of acceleration has been made, but before a judgment
or decree for payment of the money due has been obtained by the applicable trustee, the holders of at least a majority in principal amount of outstanding debt securities of such series or of all debt securities then outstanding under the applicable
indenture may rescind and annul such declaration and its consequences if: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">we have deposited with the applicable trustee all required payments of the principal, any premium, interest and,
to the extent permitted by law, interest on overdue installment of interest, plus applicable fees, expenses, disbursements and advances of the applicable trustee; and </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">all events of default, other than the <font style="white-space:nowrap">non-payment</font> of accelerated
principal, or a specified portion thereof, and any premium, have been cured or waived. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The indentures provide that holders of debt
securities of any series may not institute any proceedings, judicial or otherwise, with respect to such indenture or for any remedy under the indenture, unless the trustee fails to act for a period of 90 days after the trustee has received a written
request to institute proceedings in respect of an event of default from the holders of 25% or more in principal amount of the outstanding debt securities of such series, as well as an offer of indemnity reasonably satisfactory to the trustee.
However, this provision will not prevent any holder of debt securities from instituting suit for the enforcement of payment of the principal of, and any premium, and interest on, such debt securities at the respective due dates thereof. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The indentures provide that, subject to provisions in each indenture relating to its duties in the case of a default, a trustee has no obligation to exercise
any of its rights or powers at the request or direction of any holders of any series of debt securities then outstanding under the indenture, unless the holders have offered to the trustee reasonable security or indemnity. The holders of at least a
majority in principal amount of the outstanding debt securities of any series or of all debt securities then outstanding under an indenture shall have the right to direct the time, method and place of conducting any proceeding for any remedy
available to the applicable trustee, or of exercising any trust or power conferred upon such trustee. However, a trustee may refuse to follow any direction which: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">is in conflict with any law or the applicable indenture; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">18 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">may involve the trustee in personal liability; or </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">may be unduly prejudicial to the holders of debt securities of the series not joining the proceeding.
</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Within 120 days after the close of each fiscal year, we will be required to deliver to each trustee a certificate, signed by one of our
several specified officers, stating whether or not that officer has knowledge of any default under the applicable indenture. If the officer has knowledge of any default, the notice must specify the nature and status of the default. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Modification of the Indentures </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Subject to certain
exceptions, the indentures may be amended with the consent of the holders of a majority in aggregate principal amount of the outstanding debt securities of all series affected by such amendment (including consents obtained in connection with a
tender offer or exchange for the debt securities of such series). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We and the applicable trustee may make modifications and amendments of an indenture
without the consent of any holder of debt securities for any of the following purposes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to cure any ambiguity, defect, or inconsistency in the applicable indenture or in the Securities of any series;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to comply with the covenant described above under &ldquo;&mdash;Merger, Consolidation or Sale of Assets;&rdquo;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to provide for uncertificated debt securities in addition to or in place of certificated debt securities;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to add events of default for the benefit of the holders of all or any series of debt securities;
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to add the covenants, restrictions, conditions or provisions relating to us for the benefit of the holders of all
or any series of debt securities (and if such covenants, restrictions, conditions or provisions are to be for the benefit of less than all series of debt securities, stating that such covenants, restrictions, conditions or provisions are expressly
being included solely for the benefit of such series), to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default, or to surrender any
right or power in the applicable indenture conferred upon us; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to add to, delete from, or revise the conditions, limitations, and restrictions on the authorized amount, terms,
or purposes of issue, authentication, and delivery of debt securities, as set forth in the applicable indenture; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to make any change that does not adversely affect the rights of any holder of notes under the applicable
indenture in any material respect; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to provide for the issuance of and establish the form and terms and conditions of the debt securities of any
series as provided in the applicable indenture, to establish the form of any certifications required to be furnished pursuant to the terms of the applicable indenture or any series of debt securities under the applicable indenture, or to add to the
rights of the holders of any series of debt securities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to evidence and provide for the acceptance of appointment under the applicable indenture by a successor trustee
or to appoint a separate trustee with respect to any series; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to comply with any requirements of the SEC or any successor in connection with the qualification of the indenture
under the Trust Indenture Act of 1939, as amended, or the Trust Indenture Act; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to conform the applicable indenture to this &ldquo;&mdash;Description of Debt Securities&rdquo; or any other
similarly titled section in any prospectus supplement or other offering document relating to a series of debt securities. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">19 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Subordination </b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Payment by us of the principal of, premium, if any, and interest on any series of subordinated debt securities issued under the subordinated indenture will be
subordinated to the extent set forth in an indenture supplemental to the subordinated indenture relating to such series. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Discharge, Defeasance and
Covenant Defeasance </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Unless otherwise provided in the applicable prospectus supplement, the indentures allow us to discharge our obligations to holders
of any series of debt securities issued under any indenture when: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">either (i)&nbsp;all securities of such series have already been delivered to the applicable trustee for
cancellation; or (ii)&nbsp;all securities of such series have not already been delivered to the applicable trustee for cancellation but (a)&nbsp;have become due and payable, (b)&nbsp;will become due and payable within one year, or (c)&nbsp;if
redeemable at our option, are to be redeemed within one year, and we have irrevocably deposited with the applicable trustee, in trust, funds in such currency or currencies, or governmental obligations in an amount sufficient to pay the entire
indebtedness on such debt securities in respect of principal and any premium, and interest to the date of such deposit if such debt securities have become due and payable or, if they have not, to the stated maturity or redemption date; and
</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">we have paid or caused to be paid all other sums payable. </p></td></tr></table>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Unless otherwise provided in the applicable prospectus supplement, the indentures provide that, upon our irrevocable deposit with the applicable trustee, in
trust, of an amount, in such currency or currencies in which such debt securities are payable at stated maturity, or government obligations, or both, applicable to such debt securities, which through the scheduled payment of principal and interest
in accordance with their terms will provide money in an amount sufficient to pay the principal of, and any premium or make-whole amount, and interest on, such debt securities, and any mandatory sinking fund or analogous payments thereon, on the
scheduled due dates therefor, the issuing company shall be released from its obligations with respect to such debt securities under the applicable indenture or, if provided in the applicable prospectus supplement, its obligations with respect to any
other covenant, and any omission to comply with such obligations shall not constitute an event of default with respect to such debt securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The
applicable prospectus supplement may further describe the provisions, if any, permitting such defeasance or covenant defeasance, including any modifications to the provisions described above, with respect to the debt securities of or within a
particular series. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Conversion Rights </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The terms and
conditions, if any, upon which the debt securities are convertible into common stock or other securities of ours will be set forth in the applicable prospectus supplement. The terms will include whether the debt securities are convertible into
shares of common stock or other securities of ours, the conversion price, or manner of calculation thereof, the conversion period, provisions as to whether conversion will be at the issuing company&rsquo;s option or the option of the holders, the
events requiring an adjustment of the conversion price and provisions affecting conversion in the event of the redemption of the debt securities and any restrictions on conversion. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Governing Law </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The indentures and the debt securities
will be governed by and construed in accordance with the laws of the State of New York, except to the extent that the Trust Indenture Act is applicable. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">20 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b008_v1"></a>DESCRIPTION OF WARRANTS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><i>The following description, together with the additional information we may include in any applicable prospectus supplements, summarizes the material terms
and provisions of the warrants that we may offer under this prospectus and the related warrant agreements and warrant certificates. While the terms summarized below will apply generally to any warrants that we may offer, we will describe the
particular terms of any series of warrants in more detail in the applicable prospectus supplement. If we indicate in the prospectus supplement, the terms of any warrants offered under that prospectus supplement may differ from the terms described
below. Specific warrant agreements will contain additional important terms and provisions and will be incorporated by reference as an exhibit to the registration statement, which includes this prospectus. </i></p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>General </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may issue warrants for the purchase of common
stock, preferred stock and/or debt securities in one or more series. We may issue warrants independently or together with common stock, preferred stock and/or debt securities, and the warrants may be attached to or separate from these securities.
</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We will evidence each series of warrants by warrant certificates that we will issue under a separate warrant agreement. We will enter into the warrant
agreement with a warrant agent. We will indicate the name and address of the warrant agent in the applicable prospectus supplement relating to a particular series of warrants. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We will describe in the applicable prospectus supplement the terms of the series of warrants, including: </p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the offering price and aggregate number of warrants offered; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the currency for which the warrants may be purchased; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">if applicable, the designation and terms of the securities with which the warrants are issued and the number of
warrants issued with each such security or each principal amount of such security; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">if applicable, the date on and after which the warrants and the related securities will be separately
transferable; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon
exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or
preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and
the warrants; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the terms of any rights to redeem or call the warrants; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise
of the warrants; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the periods during which, and places at which, the warrants are exercisable; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the manner of exercise; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the dates on which the right to exercise the warrants will commence and expire; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the manner in which the warrant agreement and warrants may be modified; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">federal income tax consequences of holding or exercising the warrants; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the terms of the securities issuable upon exercise of the warrants; and </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any other specific terms, preferences, rights or limitations of or restrictions on the warrants.
</p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">21 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b009_v1"></a>DESCRIPTION OF UNITS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may issue units comprised of shares of common stock, shares of preferred stock, debt securities and warrants in any combination. We may issue units in such
amounts and in as many distinct series as we wish. This section outlines certain provisions of the units that we may issue. If we issue units, they will be issued under one or more unit agreements to be entered into between us and a bank or other
financial institution, as unit agent. The information described in this section may not be complete in all respects and is qualified entirely by reference to the unit agreement with respect to the units of any particular series. The specific terms
of any series of units offered will be described in the applicable prospectus supplement. If so described in a particular prospectus supplement, the specific terms of any series of units may differ from the general description of terms presented
below. We urge you to read any prospectus supplement related to any series of units we may offer, as well as the complete unit agreement and unit certificate that contain the terms of the units. If we issue units, forms of unit agreements and unit
certificates relating to such units will be incorporated by reference as exhibits to the registration statement, which includes this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Each
unit that we may issue will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement
under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date. The applicable prospectus supplement may describe: </p>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the designation and terms of the units and of the securities comprising the units, including whether and under
what circumstances those securities may be held or transferred separately; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any provisions of the governing unit agreement; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the price or prices at which such units will be issued; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the applicable United States federal income tax considerations relating to the units; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities
comprising the units; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any other terms of the units and of the securities comprising the units. </p></td></tr></table>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The provisions described in this section, as well as those described under the &ldquo;Description of Capital Stock,&rdquo; &ldquo;Description of Debt
Securities&rdquo; and &ldquo;Description of Warrants&rdquo; will apply to the securities included in each unit, to the extent relevant and as may be updated in any prospectus supplements. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Issuance in Series </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may issue units in such amounts
and in as many distinct series as we wish. This section summarizes terms of the units that apply generally to all series. Most of the financial and other specific terms of a particular series will be described in the applicable prospectus
supplement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b>Unit Agreements </b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We will issue the units
under one or more unit agreements to be entered into between us and a bank or other financial institution, as unit agent. We may add, replace or terminate unit agents from time to time. We will identify the unit agreement under which each series of
units will be issued and the unit agent under that agreement in the applicable prospectus supplement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">22 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The following provisions will generally apply to all unit agreements unless otherwise stated in the
applicable prospectus supplement: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Modification without Consent </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We and the applicable unit agent may amend any unit or unit agreement without the consent of any holder: </p>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to cure any ambiguity, including modifying any provisions of the governing unit agreement that differ from those
described below; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to correct or supplement any defective or inconsistent provision; or </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">to make any other change that we believe is necessary or desirable and will not adversely affect the interests of
the affected holders in any material respect. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We do not need any approval to make changes that affect only units to be issued after the
changes take effect. We may also make changes that do not adversely affect a particular unit in any material respect, even if they adversely affect other units in a material respect. In those cases, we do not need to obtain the approval of the
holder of the unaffected unit; we need only obtain any required approvals from the holders of the affected units. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Modification with Consent
</i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may not amend any particular unit or a unit agreement with respect to any particular unit unless we obtain the consent of the holder of that
unit, if the amendment would: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">impair any right of the holder to exercise or enforce any right under a security included in the unit if the
terms of that security require the consent of the holder to any changes that would impair the exercise or enforcement of that right; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">reduce the percentage of outstanding units or any series or class the consent of whose holders is required to
amend that series or class, or the applicable unit agreement with respect to that series or class, as described below. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Any other change
to a particular unit agreement and the units issued under that agreement would require the following approval: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">If the change affects only the units of a particular series issued under that agreement, the change must be
approved by the holders of a majority of the outstanding units of that series; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">If the change affects the units of more than one series issued under that agreement, it must be approved by the
holders of a majority of all outstanding units of all series affected by the change, with the units of all the affected series voting together as one class for this purpose. </p></td></tr></table>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">These provisions regarding changes with majority approval also apply to changes affecting any securities issued under a unit agreement, as the governing
document. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">In each case, the required approval must be given by written consent. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Unit Agreements Will Not Be Qualified under Trust Indenture Act </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">No unit agreement will be qualified as an indenture, and no unit agent will be required to qualify as a trustee, under the Trust Indenture Act. Therefore,
holders of units issued under unit agreements will not have the protections of the Trust Indenture Act with respect to their units. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Mergers and
Similar Transactions Permitted; No Restrictive Covenants or Events of Default </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The unit agreements will not restrict our ability to merge or
consolidate with, or sell our assets to, another corporation or other entity or to engage in any other transactions. If at any time we merge or consolidate with, or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">23 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">
sell our assets substantially as an entirety to, another corporation or other entity, the successor entity will succeed to and assume our obligations under the unit agreements. We will then be
relieved of any further obligation under these agreements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The unit agreements will not include any restrictions on our ability to put liens on our
assets, nor will they restrict our ability to sell our assets. The unit agreements also will not provide for any events of default or remedies upon the occurrence of any events of default. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Governing Law </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The unit agreements and the units
will be governed by Delaware law. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Form, Exchange and Transfer </i></b></p>
<p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We will issue each unit in global (i.e., book-entry) form only. Units in book-entry form will be represented by a global security registered in the name of a
depositary, which will be the holder of all the units represented by the global security. Those who own beneficial interests in a unit will do so through participants in the depositary&rsquo;s system, and the rights of these indirect owners will be
governed solely by the applicable procedures of the depositary and its participants. We will describe book-entry securities, and other terms regarding the issuance and registration of the units in the applicable prospectus supplement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Each unit and all securities comprising the unit will be issued in the same form. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">If we issue any units in registered, <font style="white-space:nowrap">non-global</font> form, the following will apply to them. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The units will be issued in the denominations stated in the applicable prospectus supplement. Holders may exchange their units for units of smaller
denominations or combined into fewer units of larger denominations, as long as the total amount is not changed. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">Holders may exchange or transfer their units at the office of the unit agent. Holders may also replace lost,
stolen, destroyed or mutilated units at that office. We may appoint another entity to perform these functions or perform them ourselves. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">Holders will not be required to pay a service charge to transfer or exchange their units, but they may be
required to pay for any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange, and any replacement, will be made only if our transfer agent is satisfied with the holder&rsquo;s proof of legal ownership.
The transfer agent may also require an indemnity before replacing any units. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">If we have the right to redeem, accelerate or settle any units before their maturity, and we exercise our right
as to less than all those units or other securities, we may block the exchange or transfer of those units during the period beginning 15 days before the day we mail the notice of exercise and ending on the day of that mailing, in order to freeze the
list of holders to prepare the mailing. We may also refuse to register transfers of or exchange any unit selected for early settlement, except that we will continue to permit transfers and exchanges of the unsettled portion of any unit being
partially settled. We may also block the transfer or exchange of any unit in this manner if the unit includes securities that are or may be selected for early settlement. </p></td></tr></table>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Only the depositary will be entitled to transfer or exchange a unit in global form, since it will be the sole holder of the unit. </p>
<p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif"><b><i>Payments and Notices </i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">In making payments and
giving notices with respect to our units, we will follow the procedures as described in the applicable prospectus supplement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">24 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b010_v1"></a>SELLING SECURITYHOLDERS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Selling securityholders are persons or entities that, directly or indirectly, have acquired or will from time to time acquire from us, our securities. Such
selling securityholders may be parties to a registration rights agreement with us, or we otherwise may have agreed or will agree to register the resale of their securities. If this prospectus is used by selling securityholders for the resale of any
securities registered under this registration statement, information about such selling securityholders, their beneficial ownership of our securities and their relationship with us will be set forth in a prospectus supplement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">25 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b011_v1"></a>PLAN OF DISTRIBUTION </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We or any selling securityholders may sell securities: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">through underwriters; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">through dealers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">through agents; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">directly to purchasers; or </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">through a combination of any of these methods of sale or any other method permitted by law.
</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">In addition, we may sell securities in <font style="white-space:nowrap">&ldquo;at-the</font> market&rdquo; offerings (as defined in Rule
415 under the Securities Act of 1933). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Either we or the selling securityholders may directly solicit offers to purchase securities, or agents may be
designated to solicit such offers. In the prospectus supplement relating to such offering, either we or the selling securityholders will name any agent that could be viewed as an underwriter under the Securities Act and describe any commissions that
we must pay to any such agent. Any such agent will be acting on a best efforts basis for the period of its appointment or, if indicated in the applicable prospectus supplement, on a firm commitment basis. This prospectus may be used in connection
with any offering of our securities through any of these methods, including block trades, or other methods described in the applicable prospectus supplement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The distribution of the securities may be effected from time to time in one or more transactions: </p>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">at a fixed price, or prices, which may be changed from time to time; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">at market prices prevailing at the time of sale; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">at prices related to such prevailing market prices; or </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">at negotiated prices. </p></td></tr></table>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Each prospectus supplement will describe the method of distribution of the securities and any applicable restrictions. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The prospectus supplement with respect to the securities of a particular series will describe the terms of the offering of the securities, including the
following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the name of the agent or any underwriters; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the public offering or purchase price; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any discounts and commissions to be allowed or paid to the agent or underwriters; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">all other items constituting underwriting compensation; </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any discounts and commissions to be allowed or paid to dealers; and </p></td></tr></table>
<p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">any exchanges on which the securities will be listed. </p></td></tr></table>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">If any underwriters or agents are used in the sale of the securities in respect of which this prospectus is delivered, we and/or the selling securityholders
will enter into an underwriting agreement, sales agreement or other agreement with them at the time of sale to them, and the names of the underwriters or agents and the terms of the related agreement will be set forth in the prospectus supplement
relating to such offering. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">In connection with the offering of securities, we or the selling securityholders may grant to the underwriters an option to
purchase additional securities with an additional underwriting commission, as may be set forth in the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">26 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">
accompanying prospectus supplement. If we or the selling securityholders grant any such option, the terms of such option will be set forth in the prospectus supplement for such securities. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">If a dealer is used in the sale of the securities in respect of which the prospectus is delivered, we or the selling securityholders will sell such securities
to the dealer, as principal. The dealer, who may be deemed to be an &ldquo;underwriter&rdquo; as that term is defined in the Securities Act, may then resell such securities to the public at varying prices to be determined by such dealer at the time of
resale. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Agents, underwriters, dealers and other persons may be entitled under agreements which they may enter into with us or the selling securityholders
to indemnification by us or the selling securityholders against certain civil liabilities, including liabilities under the Securities Act, and may be customers of, engage in transactions with or perform services for us in the ordinary course of
business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">If so indicated in the applicable prospectus supplement, we or the selling securityholders will authorize underwriters or other persons acting
as our agents to solicit offers by certain institutions to purchase securities from us pursuant to delayed delivery contracts providing for payment and delivery on the date stated in the prospectus supplement. Each contract will be for an amount not
less than, and the aggregate amount of securities sold pursuant to such contracts shall not be less nor more than, the respective amounts stated in the prospectus supplement. Institutions with whom the contracts, when authorized, may be made include
commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other institutions, but shall in all cases be subject to our approval. Delayed delivery contracts will not be subject
to any conditions except that: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">the purchase by an institution of the securities covered under that contract shall not at the time of delivery be
prohibited under the laws of the jurisdiction to which that institution is subject; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">if the securities are also being sold to underwriters acting as principals for their own account, the
underwriters shall have purchased such securities not sold for delayed delivery. The underwriters and other persons acting as our agents will not have any responsibility in respect of the validity or performance of delayed delivery contracts.
</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Offered securities may also be offered and sold, if so indicated in the prospectus supplement, in connection with a remarketing upon
their purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more remarketing firms, acting as principals for their own accounts or as agents for us or the selling securityholders. Any remarketing
firm will be identified and the terms of its agreement, if any, with us or the selling securityholders and its compensation will be described in the applicable prospectus supplement. Remarketing firms may be deemed to be underwriters in connection
with their remarketing of offered securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Certain agents, underwriters and dealers, and their associates and affiliates, may be customers of, have
borrowing relationships with, engage in other transactions with, or perform services, including investment banking services, for us or one or more of our respective affiliates in the ordinary course of business. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">In order to facilitate the offering of the securities, any underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of
the securities or any other securities the prices of which may be used to determine payments on such securities. Specifically, any underwriters may overallot in connection with the offering, creating a short position for their own accounts. In
addition, to cover overallotments or to stabilize the price of the securities or of any such other securities, the underwriters may bid for, and purchase, the securities or any such other securities in the open market. Finally, in any offering of
the securities through a syndicate of underwriters, the underwriting syndicate may reclaim selling concessions allowed to an underwriter or a dealer for distributing the securities in the offering if the syndicate repurchases previously distributed
securities in transactions to cover syndicate short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market levels. Any such underwriters
are not required to engage in these activities and may end any of these activities at any time. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">27 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We may engage in &ldquo;at the market&rdquo; offerings to or through a market maker or into an existing
trading market in accordance with Rule 415(a)(4) under the Securities Act. In addition, we or the selling securityholders may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties
in privately negotiated transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in
short sale transactions. If so, the third party may use securities pledged by us or the selling securityholders or borrowed from us or the selling securityholders or others to settle those sales or to close out any related open borrowings of stock,
and may use securities received from us or the selling securityholders in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and, if not identified in
this prospectus, will be named in the applicable prospectus supplement (or a post-effective amendment). In addition, we or the selling securityholders may otherwise loan or pledge securities to a financial institution or other third party that in
turn may sell the securities short using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a
concurrent offering of other securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Under Rule <font style="white-space:nowrap">15c6-1</font> of the Exchange Act, trades in the secondary market
generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. The applicable prospectus supplement may provide that the original issue date for your securities may be more than one scheduled
business day after the trade date for your securities. Accordingly, in such a case, if you wish to trade securities on any date prior to the business day before the original issue date for your securities, you will be required, by virtue of the fact
that your securities initially are expected to settle in more than one scheduled business day after the trade date for your securities, to make alternative settlement arrangements to prevent a failed settlement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The securities may be new issues of securities and may have no established trading market. The securities may or may not be listed on a national securities
exchange. We can make no assurance as to the liquidity of or the existence of trading markets for any of the securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The specific terms of any <font style="white-space:nowrap">lock-up</font> provisions in respect of any given offering will be described in the applicable prospectus supplement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The
underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation. </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The anticipated date of delivery of offered securities will be set forth in the applicable prospectus supplement relating to each offer. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">28 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b012_v1"></a>LEGAL MATTERS </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The validity of the securities offered by this prospectus will be passed upon for us by Goodwin Procter LLP, Redwood City, California. </p>
<p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b013_v1"></a>EXPERTS </b></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The
financial statements of Rocket Lab USA, Inc. incorporated by reference in this Prospectus, and the effectiveness of Rocket Lab USA, Inc.&rsquo;s internal control over financial reporting have been audited by Deloitte &amp; Touche LLP, an independent
registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm, given their authority as experts in accounting and auditing. </p>
<p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b014_v1"></a>WHERE YOU CAN FIND MORE INFORMATION </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet site that contains reports,
proxy and information statements, and other information regarding us. Our SEC filings are available to the public over the Internet at the SEC&rsquo;s website at <i>www.sec.gov</i>. Copies of certain information filed by us with the SEC are also
available on our website at <i>www.rocketlabusa.com</i>. Our website and the information contained or connected to our website is not a part of this prospectus or any prospectus supplement and is not incorporated by reference in this prospectus or
any prospectus supplement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">This prospectus is part of a registration statement on Form <font style="white-space:nowrap">S-3</font> we filed with the SEC
under the Securities Act with respect to the securities offered by this prospectus and the applicable prospectus supplement. This prospectus and the applicable prospectus supplement do not contain all of the information set forth in the registration
statement and its exhibits and schedules in accordance with SEC rules and regulations. For further information with respect to us and the securities being offered by this prospectus and the applicable prospectus supplement, you should read the
registration statement of which this prospectus is a part, including its exhibits and schedules. Statements contained in this prospectus and the applicable prospectus supplement, including documents that we have incorporated by reference, as to the
contents of any contract or other document referred to are not necessarily complete, and, with respect to any contract or other document filed as an exhibit to the registration statement or any other such document, each such statement is qualified
in all respects by reference to the corresponding exhibit. You should review the complete contract or other document to evaluate these statements. You may obtain copies of the registration statement and its exhibits via the SEC&rsquo;s EDGAR database
or our website. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">29 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center"><b><a name="b015_v1"></a>INCORPORATION BY REFERENCE </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">The SEC allows us to incorporate by reference the information we file with the SEC, which means that we can disclose important information to you by referring
you to those publicly available documents. The information that we incorporate by reference in this prospectus is considered to be part of this prospectus. Because we are incorporating by reference future filings with the SEC, this prospectus is
continually updated and those future filings may modify or supersede some of the information included or incorporated in this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of
the statements in this prospectus or in any document previously incorporated by reference have been modified or superseded. This prospectus incorporates by reference the documents listed below and any documents subsequently filed by us with the SEC
under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (in each case, other than those documents or the portions of those documents deemed furnished and not filed in accordance with SEC rules, including Items 2.02 and 7.01 of Form <font style="white-space:nowrap">8-K)</font> until the offering of the securities under the registration statement is terminated or completed: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">Annual Report on <a href="http://www.sec.gov/Archives/edgar/data/1819994/000162828025008724/rklb-20241231.htm">Form
 <font style="white-space:nowrap">10-K</font></a> for the year ended December&nbsp;31, 2024, filed with the SEC on February&nbsp;27, 2025; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">Current Report on Form <font style="white-space:nowrap">8-K</font> filed with the SEC on <a href="http://www.sec.gov/Archives/edgar/data/0001819994/000162828025001137/rklb-20250107.htm">January&nbsp;10,
 2025</a>; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman, Times, Serif; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
<tr style="page-break-inside:avoid">
<td width="5%">&nbsp;</td>
<td width="3%" valign="top" align="left">&bull;</td>
<td width="1%" valign="top">&nbsp;</td>
<td align="left" valign="top"> <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman, Times, Serif; font-size:10pt">The description of our capital stock contained on <a href="http://www.sec.gov/Archives/edgar/data/1819994/000110465920108236/tm2026739d9_8a12b.htm">Form
 <font style="white-space:nowrap">8-A</font></a> filed on September&nbsp;
24, 2020, as the description therein has been updated and superseded by the description of our capital stock contained in <a href="http://www.sec.gov/Archives/edgar/data/1819994/000162828025008724/rklb-ex4_1.htm">Exhibit 4.1</a> to our Annual Report
on Form <font style="white-space:nowrap">10-K</font> filed with the SEC on February&nbsp;27, 2025 including any amendments or reports filed for the purpose of updating such description. </p></td></tr></table>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">Upon request, we will provide, without charge, to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, upon written or
oral request, a copy of the documents incorporated by reference into this prospectus but not delivered with the prospectus. You may request a copy of these filings, and any exhibits we have specifically incorporated by reference as an exhibit in
this prospectus, at no cost by contacting us at the following address and telephone number: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">Rocket Lab USA, Inc. </p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">3881 McGowen Street </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">Long Beach,
California 90808 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">Attention: Corporate Secretary </p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">(714) <font style="white-space:nowrap">465-5737</font> </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">You may also access these documents, free of charge on the SEC&rsquo;s website at <i>www.sec.gov</i> or on our website at <i>www.rocketlabusa.com</i>.
Information contained on our website is not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our website as part of this prospectus or any accompanying prospectus
supplement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">This prospectus is part of a registration statement we filed with the SEC. We have incorporated exhibits into this registration statement.
You should read the exhibits carefully for provisions that may be important to you. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif">We have not authorized anyone to provide you any information other
than that contained or incorporated by reference into this prospectus. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this prospectus or in the documents
incorporated by reference is accurate as of any date other than the date on the front of this prospectus or those documents. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman, Times, Serif" align="center">30 </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr size="3" style="COLOR:#999999" width="100%" align="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<center><div style="width:8.5in" align="left">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Up
to $750,000,000</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Common
Stock </B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><IMG SRC="img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>PROSPECTUS
SUPPLEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>BofA
    Securities</B></FONT></TD>
    <TD STYLE="width: 33%; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Cantor</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>BTIG</B></FONT></TD>
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Citizens
    Capital Markets</B></FONT></TD>
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>KeyBanc
    Capital Markets</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Needham
    &amp; Company</B></FONT></TD>
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Roth
    Capital Partners</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>September
15, 2025 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
</div></center>






</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>g084949_ex107.htm
<DESCRIPTION>EXHIBIT 107
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:rklb="http://Rocklabcorp.in/20250915">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_027_FFD%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_rklb_Rocklabcorp.in_20250915 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20250915_20250915 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001819994 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-15" id="Fact000003" name="dei:EntityCentralIndexKey">0001819994</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-15" id="xdx2ixbrl0009" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-15" id="xdx2ixbrl0010" name="ffd:SubmissnTp">424B5</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-15" id="xdx2ixbrl0011" name="ffd:FormTp">S-3</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-15" id="xdx2ixbrl0012" name="ffd:OfferingTableNa" xs:nil="true"></ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-09-152025-09-15_1" id="xdx2ixbrl0017" name="ffd:OfferingSctyTp">Equity</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819994</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-15</xbrli:startDate>
        <xbrli:endDate>2025-09-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-09-152025-09-15_1">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819994</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>1</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-15</xbrli:startDate>
        <xbrli:endDate>2025-09-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_effd--FeeExhibitTp_dxL_c20250915__20250915_z2lVNMsQ3H39" title="::XDX::EX-FILING FEES"><span style="-sec-ix-hidden: xdx2ixbrl0009">Exhibit
107 </span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calculation
of Filing Fee Tables </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Form
<span id="xdx_902_effd--SubmissnTp_dxL_c20250915__20250915_zZ0JuUKJFGa5" title="::XDX::424B5"><span id="xdx_90A_effd--FormTp_dxL_c20250915__20250915_zpwRhd69BJo6" title="::XDX::S-3"><span style="-sec-ix-hidden: xdx2ixbrl0010"><span style="-sec-ix-hidden: xdx2ixbrl0011">424(b)(5)</span></span></span></span>&#160;</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)<span id="xdx_90F_effd--OfferingTableNa_c20250915__20250915_zk49lew6wYuf" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0012">-</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityRegistrantName_c20250915__20250915_zhYwDpkgc3y3"><ix:nonNumeric contextRef="AsOf2025-09-15" id="Fact000013" name="dei:EntityRegistrantName">Rocket
Lab Corporation</ix:nonNumeric></span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)<span id="xdx_90B_effd--OffsetTableNa_c20250915__20250915_zWxC8qPNvIAc"><span id="xdx_904_effd--CombinedProspectusTableNa_c20250915__20250915_zcpZvLZxYoH9" style="display: none"><ix:nonNumeric contextRef="AsOf2025-09-15" id="Fact000014" name="ffd:OffsetTableNa"><ix:nonNumeric contextRef="AsOf2025-09-15" id="Fact000015" name="ffd:CombinedProspectusTableNa">N/A</ix:nonNumeric></ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Table
1: Newly Registered and Carry Forward Securities </span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
Carry</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
Per</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unit</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
of</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee</span></p></td></tr>
<tr>
    <td colspan="17" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="17" style="border-right: black 1pt solid; border-left: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newly
    Registered Securities</span></td></tr>
<tr>
    <td style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-left: black 1pt solid"><p id="xdx_98D_effd--PrevslyPdFlg_dbF_c20250915__20250915__ffd--OfferingAxis__1_zNKTxKEzAdJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-09-152025-09-15_1" format="ixt:booleanfalse" id="Fact000016" name="ffd:PrevslyPdFlg">Fees
to Be Paid</ix:nonNumeric></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_effd--OfferingSctyTp_dxL_c20250915__20250915__ffd--OfferingAxis__1_zpFy5QAeDe0c" title="::XDX::Equity" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8201;<span style="-sec-ix-hidden: xdx2ixbrl0017">Equity&#8201;</span></span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_effd--OfferingSctyTitl_c20250915__20250915__ffd--OfferingAxis__1_zcjIOwk9Jxz2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-09-152025-09-15_1" id="Fact000018" name="ffd:OfferingSctyTitl">Common Stock, par
    value $0.0001 per share</ix:nonNumeric></span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_effd--Rule457oFlg_dbT_c20250915__20250915__ffd--OfferingAxis__1_z5z9lQyUJGQ" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-09-152025-09-15_1" format="ixt:booleantrue" id="Fact000019" name="ffd:Rule457oFlg">457(o)</ix:nonNumeric></span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_effd--MaxAggtOfferingPric_c20250915__20250915__ffd--OfferingAxis__1_zIxThPtyg0Ji" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="From2025-09-152025-09-15_1" id="Fact000020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">750,000,000</ix:nonFraction></span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_effd--FeeRate_c20250915__20250915__ffd--OfferingAxis__1_zmVAIeTzMoPd" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ffd:FeeRate" contextRef="From2025-09-152025-09-15_1" id="Fact000021" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">0.00015310</ix:nonFraction></span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_909_effd--FeeAmt_pp2p0_c20250915__20250915__ffd--OfferingAxis__1_zVsrOFi1Iava"><ix:nonFraction name="ffd:FeeAmt" contextRef="From2025-09-152025-09-15_1" id="Fact000022" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">114,825.00</ix:nonFraction></span>(1)</span></td></tr>
<tr style="background-color: White">
    <td style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-left: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paid</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
<tr style="background-color: White">
    <td colspan="17" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="17" style="border-right: black 1pt solid; border-left: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry
    Forward Securities</span></td></tr>
<tr style="background-color: White">
    <td style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-left: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities</span></p></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;&#8194;</span></td></tr>
<tr style="background-color: White">
    <td style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="8" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Offering Amounts&#8201;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_effd--TtlOfferingAmt_c20250915__20250915_zy0Pzz6AYwMj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="AsOf2025-09-15" id="Fact000023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">750,000,000</ix:nonFraction></span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_effd--TtlFeeAmt_pp2p0_c20250915__20250915_z63C2tq6Jo8k"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="AsOf2025-09-15" id="Fact000024" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">114,825.00</ix:nonFraction></span></span></td></tr>
<tr style="background-color: White">
    <td style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="8" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Fees Previously Paid&#8201;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_effd--TtlPrevslyPdAmt_d0_c20250915__20250915_zFXQUXZ9Dpla" style="border-right: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="AsOf2025-09-15" id="Fact000025" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></span></td></tr>
<tr style="background-color: White">
    <td style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="8" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Fee Offsets&#8201;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_effd--TtlOffsetAmt_d0_c20250915__20250915_zvh5tUGhzZie" style="border-right: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="AsOf2025-09-15" id="Fact000026" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></span></td></tr>
<tr style="background-color: White">
    <td style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="8" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Fee Due&#8201;</span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_905_effd--NetFeeAmt_pp2p0_c20250915__20250915_zTxI9f9gHThk"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="AsOf2025-09-15" id="Fact000027" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">114,825.00</ix:nonFraction></span>(1)</span></td></tr>
</table>

<ix:nonNumeric contextRef="From2025-09-152025-09-15_1" escape="true" id="Fact000029" name="ffd:OfferingNote"><p id="xdx_84E_effd--OfferingNote_hffd--OfferingAxis__1_dU_zSKd9eTMFRsj" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registration fee is calculated in accordance
    with Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), based on the proposed maximum
    aggregate offering price. In accordance with Rules 456(b) and 457(r) under the Securities Act, Rocket Lab USA, Inc. (the &#8220;Predecessor
    Registrant&#8221;) initially deferred payment of all of the registration fees for the Registration Statement on Form S-3 (Registration
    No. <span id="xdx_90F_effd--RegnFileNb_c20250915__20250915_zcHqbxcC7xKk"><ix:nonNumeric contextRef="AsOf2025-09-15" id="Fact000030" name="ffd:RegnFileNb">333-285707</ix:nonNumeric></span>) filed with the Securities and Exchange Commission on March 11, 2025 (as amended, the &#8220;Registration Statement&#8221;).
    Rocket Lab Corporation became the successor to the Predecessor Registrant on May 23, 2025. This &#8220;Calculation of Filing
    Fee Tables&#8221; shall be deemed to update the &#8220;Calculation of Registration Fee Tables&#8221; in the Registration Statement.
    </span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_85D_zduBhFJrgshb" style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>

    <!-- Field: /Page -->

<p style="margin: 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdoOFNylQ0WcMoaIt8VlUuyakda/R/ItrRtiCITknC9HiJFY08pYZDgtqgIO2HZWB4QKG2R0Z4yOfLPNIM4KL8YH1i706w8s7c3DbKx0vPWuu/FYZyDnEzWdpFNQMpMSyp1IvnpOrjE1umC0Be1qKJk6Nhg0v4YPB/0kR+2rTzkie0MuAzWWg/yGVKoU9nTXD+Krh6LIRTLqKxFrplsXXctnQPclYWmxjXF+oP+dfABKbkjC -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 5 #? P$1  (1 0,1 ?_$ -   0 " @(" P
M       ("0<*! L%!@$" P$! 0$!  ,! 0$           $" P4&!P0("1
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M.J7UQ:)*KD#U26SV5ZK-.CUB];F$%&ZSFZM)LW( 'M%-PS>*HG*/@=)0Q1Q
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MUI JWHZAK1"/^%_HT'ZM46FT/H_ON43X8_5%9U>X[JR(<1 " $ ( 0 @! "
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M$#KN78F* D16,25X(LMD=IV[,4XB $ ( 0 @! " $ ( 0 @! " $ ( 0 @!
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M5 H'$<SWR $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0
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M/%:1HFW<_N=.&LID[F9U(I3E-TT[JJ8(2V0(?C)A/#RQD<J+,GQ57 @F'O#
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MC6X\L[[.]PPX+^)WC/S]XP]W9V-KZ(W;\3#\M,/69E@KMK6A&0/(!_CT8_\
M6+_I1I^+]VO<9^3KIWDD]/?D3X%?CD+J]S?TAK+G3J#S7U>Z8\#<<P=.^*_&
>SLK8V=R_%[QD;7NY<8EXE56E*]5"QP;:5K3O/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>5
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Sep. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001819994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Rocket
Lab Corporation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-285707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Sep. 15, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par
    value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 114,825.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><p id="xdx_84E_effd--OfferingNote_hffd--OfferingAxis__1_dU_zSKd9eTMFRsj" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registration fee is calculated in accordance
    with Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), based on the proposed maximum
    aggregate offering price. In accordance with Rules 456(b) and 457(r) under the Securities Act, Rocket Lab USA, Inc. (the &#8220;Predecessor
    Registrant&#8221;) initially deferred payment of all of the registration fees for the Registration Statement on Form S-3 (Registration
    No. <span id="xdx_90F_effd--RegnFileNb_c20250915__20250915_zcHqbxcC7xKk">333-285707</span>) filed with the Securities and Exchange Commission on March 11, 2025 (as amended, the &#8220;Registration Statement&#8221;).
    Rocket Lab Corporation became the successor to the Predecessor Registrant on May 23, 2025. This &#8220;Calculation of Filing
    Fee Tables&#8221; shall be deemed to update the &#8220;Calculation of Registration Fee Tables&#8221; in the Registration Statement.
    </span></td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Sep. 15, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">114,825.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 114,825.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="g084949_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="g084949_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="g084949_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="g084949_ex107.htm">g084949_ex107.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "g084949_ex107.htm": {
   "dts": {
    "inline": {
     "local": [
      "g084949_ex107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 20,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-15",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084949_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-15",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084949_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2025-09-152025-09-15_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084949_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-09-152025-09-15_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084949_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-15",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084949_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-15",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "g084949_ex107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001753926-25-001486-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001753926-25-001486-xbrl.zip
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=,3 W+FAT;5!+!08      0 ! #\   !.$      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>g084949_ex107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="AsOf2025-09-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819994</identifier>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <context id="From2025-09-152025-09-15_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819994</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-15" id="Fact000003">0001819994</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="AsOf2025-09-15" id="xdx2ixbrl0009">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:SubmissnTp contextRef="AsOf2025-09-15" id="xdx2ixbrl0010">424B5</ffd:SubmissnTp>
    <ffd:FormTp contextRef="AsOf2025-09-15" id="xdx2ixbrl0011">S-3</ffd:FormTp>
    <ffd:OfferingTableNa
      contextRef="AsOf2025-09-15"
      id="xdx2ixbrl0012"
      xsi:nil="true"/>
    <ffd:OfferingSctyTp contextRef="From2025-09-152025-09-15_1" id="xdx2ixbrl0017">Equity</ffd:OfferingSctyTp>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-15" id="Fact000013">Rocket Lab Corporation</dei:EntityRegistrantName>
    <ffd:OffsetTableNa contextRef="AsOf2025-09-15" id="Fact000014">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="AsOf2025-09-15" id="Fact000015">N/A</ffd:CombinedProspectusTableNa>
    <ffd:PrevslyPdFlg contextRef="From2025-09-152025-09-15_1" id="Fact000016">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTitl contextRef="From2025-09-152025-09-15_1" id="Fact000018">Common Stock, par     value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="From2025-09-152025-09-15_1" id="Fact000019">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="From2025-09-152025-09-15_1"
      decimals="0"
      id="Fact000020"
      unitRef="USD">750000000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="From2025-09-152025-09-15_1"
      decimals="INF"
      id="Fact000021"
      unitRef="Ratio">0.00015310</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="From2025-09-152025-09-15_1"
      decimals="2"
      id="Fact000022"
      unitRef="USD">114825.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="AsOf2025-09-15"
      decimals="0"
      id="Fact000023"
      unitRef="USD">750000000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="AsOf2025-09-15"
      decimals="2"
      id="Fact000024"
      unitRef="USD">114825.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="AsOf2025-09-15"
      decimals="0"
      id="Fact000025"
      unitRef="USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="AsOf2025-09-15"
      decimals="0"
      id="Fact000026"
      unitRef="USD">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="AsOf2025-09-15"
      decimals="2"
      id="Fact000027"
      unitRef="USD">114825.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="From2025-09-152025-09-15_1" id="Fact000029">&lt;p id="xdx_84E_effd--OfferingNote_hffd--OfferingAxis__1_dU_zSKd9eTMFRsj" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The registration fee is calculated in accordance
    with Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), based on the proposed maximum
    aggregate offering price. In accordance with Rules 456(b) and 457(r) under the Securities Act, Rocket Lab USA, Inc. (the &#x201c;Predecessor
    Registrant&#x201d;) initially deferred payment of all of the registration fees for the Registration Statement on Form S-3 (Registration
    No. &lt;span id="xdx_90F_effd--RegnFileNb_c20250915__20250915_zcHqbxcC7xKk"&gt;333-285707&lt;/span&gt;) filed with the Securities and Exchange Commission on March 11, 2025 (as amended, the &#x201c;Registration Statement&#x201d;).
    Rocket Lab Corporation became the successor to the Predecessor Registrant on May 23, 2025. This &#x201c;Calculation of Filing
    Fee Tables&#x201d; shall be deemed to update the &#x201c;Calculation of Registration Fee Tables&#x201d; in the Registration Statement.
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</ffd:OfferingNote>
    <ffd:RegnFileNb contextRef="AsOf2025-09-15" id="Fact000030">333-285707</ffd:RegnFileNb>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
